{"markup":"\u003C?xml version=\u00221.0\u0022 encoding=\u0022UTF-8\u0022 ?\u003E\n    \u003Chtml version=\u0022HTML+RDFa+MathML 1.1\u0022\n    xmlns:content=\u0022http:\/\/purl.org\/rss\/1.0\/modules\/content\/\u0022\n    xmlns:dc=\u0022http:\/\/purl.org\/dc\/terms\/\u0022\n    xmlns:foaf=\u0022http:\/\/xmlns.com\/foaf\/0.1\/\u0022\n    xmlns:og=\u0022http:\/\/ogp.me\/ns#\u0022\n    xmlns:rdfs=\u0022http:\/\/www.w3.org\/2000\/01\/rdf-schema#\u0022\n    xmlns:sioc=\u0022http:\/\/rdfs.org\/sioc\/ns#\u0022\n    xmlns:sioct=\u0022http:\/\/rdfs.org\/sioc\/types#\u0022\n    xmlns:skos=\u0022http:\/\/www.w3.org\/2004\/02\/skos\/core#\u0022\n    xmlns:xsd=\u0022http:\/\/www.w3.org\/2001\/XMLSchema#\u0022\n    xmlns:mml=\u0022http:\/\/www.w3.org\/1998\/Math\/MathML\u0022\u003E\n  \u003Chead\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_YjAJQgxDlFX6S-O02jj9jCrVbrwlY3CGgCg1FzPlvBs.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nif(typeof window.MathJax === \u0022undefined\u0022) window.MathJax = { menuSettings: { zoom: \u0022Click\u0022 } };\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_waP91NpgGpectm_6Y2XDEauLJ8WCSCBKmmA87unpp2E.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.googletagmanager.com\/gtag\/js?id=G-0K57TCX5BY\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nwindow.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag(\u0022js\u0022, new Date());gtag(\u0022set\u0022, \u0022developer_id.dMDhkMT\u0022, true);gtag(\u0022config\u0022, \u0022G-0K57TCX5BY\u0022, {\u0022groups\u0022:\u0022default\u0022,\u0022anonymize_ip\u0022:true});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\njQuery.extend(Drupal.settings, {\u0022basePath\u0022:\u0022\\\/\u0022,\u0022pathPrefix\u0022:\u0022\u0022,\u0022highwire\u0022:{\u0022ac\u0022:{\u0022medrxiv;2024.09.23.24313920v1\u0022:{\u0022access\u0022:{\u0022full\u0022:true},\u0022pisa_id\u0022:\u0022medrxiv;2024.09.23.24313920v1\u0022,\u0022apath\u0022:\u0022\u0022,\u0022jcode\u0022:\u0022medrxiv\u0022}},\u0022processed\u0022:[\u0022highwire_math\u0022],\u0022markup\u0022:[{\u0022requested\u0022:\u0022full-text\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022medrxiv;2024.09.23.24313920v1\u0022}]},\u0022instances\u0022:\u0022{\\u0022highwire_abstract_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:20,\\u0022height\\u0022:20,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-abstract-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022right center\\u0022,\\u0022my\\u0022:\\u0022left center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022shift\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter click \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_author_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-author-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022top center\\u0022,\\u0022my\\u0022:\\u0022bottom center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_reflinks_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022mimic\\u0022:\\u0022top center\\u0022,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-ref-link-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022bottom left\\u0022,\\u0022my\\u0022:\\u0022top left\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022flip\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}}}\u0022,\u0022qtipDebug\u0022:\u0022{\\u0022leaveElement\\u0022:0}\u0022,\u0022googleanalytics\u0022:{\u0022account\u0022:[\u0022G-0K57TCX5BY\u0022],\u0022trackOutbound\u0022:1,\u0022trackMailto\u0022:1,\u0022trackDownload\u0022:1,\u0022trackDownloadExtensions\u0022:\u00227z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip\u0022,\u0022trackColorbox\u0022:1},\u0022ajaxPageState\u0022:{\u0022js\u0022:{\u0022\\\/\\\/cdn.jsdelivr.net\\\/qtip2\\\/2.2.1\\\/jquery.qtip.min.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_article_reference_popup.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_at_symbol.js\u0022:1,\u00220\u0022:1,\u0022sites\\\/all\\\/modules\\\/contrib\\\/google_analytics\\\/googleanalytics.js\u0022:1,\u0022https:\\\/\\\/www.googletagmanager.com\\\/gtag\\\/js?id=G-0K57TCX5BY\u0022:1,\u00221\u0022:1}}});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__dn-cpI1YtkU_iLHgA5WhlkxgYWyat_IxjF_B-WSYrpE__a9hIbt0eaZ7d5nhwnm2weG8R_2eXK4EvoOx9dOxouHE__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__HGACIFBlu2o05y3afvqlt5wrE_5Dn6MXsexfuEpeIwg__t4SOPxucAPoV3Os7g8dXqyMB1HRXQridRJ82X7nE33E__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink rel=\u0027stylesheet\u0027 type=\u0027text\/css\u0027 href=\u0027\/sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css\u0027 \/\u003E\u003C\/head\u003E\u003Cbody\u003E\u003Cdiv class=\u0022panels-ajax-tab-panel panels-ajax-tab-panel-article-tab-full-text\u0022\u003E\u003Cdiv class=\u0022panel-display panel-1col clearfix\u0022 \u003E\n  \u003Cdiv class=\u0022panel-panel panel-col\u0022\u003E\n    \u003Cdiv\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup\u0022 \u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 data-highwire-cite-ref-tooltip-instance=\u0022highwire_reflinks_tooltip\u0022 class=\u0022content-block-markup\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cdiv class=\u0022article fulltext-view \u0022\u003E\u003Cspan class=\u0022highwire-journal-article-marker-start\u0022\u003E\u003C\/span\u003E\u003Cdiv class=\u0022section abstract\u0022 id=\u0022abstract-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAbstract\u003C\/h2\u003E\u003Cp id=\u0022p-4\u0022\u003EAnti-bacterial monoclonal antibody (mAb) therapies either rely on toxin neutralization or opsonophagocytic killing (OPK). Toxin neutralization protects the host from toxin-induced damage, while leaving the organism intact. OPK inducing antibodies clear the bacteria but leave the released toxins unencountered. Infection site targeted anti-toxin antibodies (ISTAbs) that we report here addresses this binary paradigm by combining both functionalities into a single molecule. ISTAbs consist of cell wall targeting (CWT) domains of bacteriophage endolysins fused to toxin neutralizing mAbs (IgG). CWT governs specific binding to the surface of bacteria while the IgG variable domain neutralizes the toxins as they are released. The complex is then cleared by phagocytic cells. As proof of concept, we generated several ISTAb prototypes targeting major toxins from two Gram-positive spore forming pathogens that have a high clinical significance; \u003Cem\u003EClostridium difficile\u003C\/em\u003E, causative agent of the most common hospital-acquired infection, and \u003Cem\u003EBacillus anthracis\u003C\/em\u003E, a Category A select agent pathogen. Both groups of ISTAbs exhibited potent toxin neutralization, binding to their respective bacterial cells, and induction of opsonophagocytosis. In mice infected with \u003Cem\u003EB. anthracis\u003C\/em\u003E, ISTAbs exhibit significantly higher efficacy than parental IgG in both pre- and post-challenge models. Furthermore, ISTAbs fully protected against \u003Cem\u003EB. anthracis\u003C\/em\u003E infection in a nonhuman primate (NHP) aerosol challenge model. These findings establish that as a platform technology, ISTAbs are broadly applicable for therapeutic intervention against several toxigenic bacterial pathogens.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EIntroduction\u003C\/h2\u003E\u003Cp id=\u0022p-17\u0022\u003EThe success of antibiotics effectively ended the use of convalescent serum therapy for bacterial infections. However, emergence of multiple antibiotic-resistant pathogens, coupled with success of immunotherapeutics in oncology and rheumatology and advancements in biological manufacturing processes, have renewed interest in antibody-based therapeutics to address bacterial infections (\u003Cem\u003E\u003Ca id=\u0022xref-ref-1-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-1\u0022\u003E1\u003C\/a\u003E\u003C\/em\u003E). Monoclonal antibodies (mAbs) can act by neutralizing secreted virulence factors such as toxins, or through bactericidal functions or opsonophagocytic killing (OPK) upon binding surface antigens. mAbs offer many unique advantages over conventional antimicrobials by \u003Cem\u003Ei)\u003C\/em\u003E being highly target-specific, thus sparing the natural microbiome, \u003Cem\u003Eii)\u003C\/em\u003E exerting less selective pressure for development of resistance than antibiotics, and \u003Cem\u003Eiii)\u003C\/em\u003E having superior safety, tolerability, and pharmacokinetic profiles over most antibiotics. Furthermore, their complementary mechanism of action can exhibit synergy with antibiotics (\u003Cem\u003E\u003Ca id=\u0022xref-ref-2-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E\u003C\/em\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-18\u0022\u003EAs a proof of concept, we chose two clinically significant spore-forming Gram-positive bacteria, \u003Cem\u003EB. anthracis\u003C\/em\u003E and \u003Cem\u003EC. difficile\u003C\/em\u003E, to generate prototype engineered mAbs referred to as \u201cInfection Site Targeted Anti-toxin Antibodies (ISTAbs)\u201d, to integrate both toxin neutralization and OPK into a single molecule. Toxins are critical for pathogenesis of both bacterial species (\u003Cem\u003E\u003Ca id=\u0022xref-ref-3-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-3\u0022\u003E3\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-6-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E\u003C\/em\u003E). Virulent \u003Cem\u003EB. anthracis\u003C\/em\u003E encodes two bicomponent protein exotoxin complexes, collectively called \u201canthrax toxin\u201d, consisting of the protective antigen (PA), which mediates binding to cell surface, along with a catalytic component. The catalytic components of the lethal toxin (LT) is the Zn\u003Csup\u003E2+\u003C\/sup\u003E protease lethal factor (LF) (\u003Cem\u003E\u003Ca id=\u0022xref-ref-7-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-7\u0022\u003E7\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-8-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-8\u0022\u003E8\u003C\/a\u003E\u003C\/em\u003E), while the adenylyl cyclase edema factor (EF) serves as the catalytic component of edema toxin (ET), (\u003Cem\u003E\u003Ca id=\u0022xref-ref-9-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-9\u0022\u003E9\u003C\/a\u003E\u003C\/em\u003E), which elevates cellular cyclic AMP levels. PA delivers LF and EF to the cytosol and is therefore a key target for immunotherapy (\u003Cem\u003E\u003Ca id=\u0022xref-ref-4-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-4\u0022\u003E4\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-6-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E\u003C\/em\u003E). Similarly, the pathogenesis of \u003Cem\u003EC. difficile\u003C\/em\u003E is largely driven by GTPase-inactivating toxins TcdB and TcdA (\u003Cem\u003E\u003Ca id=\u0022xref-ref-3-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-3\u0022\u003E3\u003C\/a\u003E\u003C\/em\u003E). To-date, three FDA approved mAbs are available for bacterial infections and all are anti-toxin antibodies. Raxibacumab and obiltoxaximab, approved in 2012 and 2016 respectively, both target PA. Bezlotoxumab, approved in 2016, targets \u003Cem\u003EC. difficile\u003C\/em\u003E TcdB. At least five mAbs are in human clinical trials that target surface epitopes of \u003Cem\u003EStaphylococcus aureus\u003C\/em\u003E or \u003Cem\u003EPseudomonas aeruginosa\u003C\/em\u003E, mediating OPK (\u003Cem\u003E\u003Ca id=\u0022xref-ref-10-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-10\u0022\u003E10\u003C\/a\u003E\u003C\/em\u003E). However, to date no bifunctional antibodies have been reported that combine toxin neutralization with OPK activity.\u003C\/p\u003E\u003Cp id=\u0022p-19\u0022\u003ETo target anti-toxin mAbs to the bacterial surface, which is required for inducing OPK, we exploited the binding properties of bacteriophage-encoded cell wall hydrolases, known as endolysins. Endolysins attack major peptidoglycan bonds, resulting in cell lysis and release of progeny phage (\u003Cem\u003E\u003Ca id=\u0022xref-ref-11-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-11\u0022\u003E11\u003C\/a\u003E\u003C\/em\u003E). Endolysins derived from phages that infect Gram-positive hosts often display a modular structure, with one or more N-terminal catalytic domains fused to a C-terminal cell wall targeting domain (CWT) via an 8-20 residue flexible linker. Significantly, through co-evolution with their bacterial hosts, phage have developed CWTs that bind with high-affinity (nM - pM) to species-specific cell wall teichoic acids or carbohydrates in order to achieve efficient host lysis. Notably, fusion with endolysin CWTs can target heterologous proteins to the surface of target organisms, such as heterologous endolysin catalytic domains (\u003Cem\u003E\u003Ca id=\u0022xref-ref-12-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-12\u0022\u003E12\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-15-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E\u003C\/em\u003E), green fluorescence protein (GFP) (\u003Cem\u003E\u003Ca id=\u0022xref-ref-16-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-16\u0022\u003E16\u003C\/a\u003E\u003C\/em\u003E), or bacteriocins (\u003Cem\u003E\u003Ca id=\u0022xref-ref-17-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-17\u0022\u003E17\u003C\/a\u003E\u003C\/em\u003E). Endolysins from \u003Cem\u003EBacillus\u003C\/em\u003E phage have well-defined CWTs that typically bind the \u003Cem\u003EB. anthracis\u003C\/em\u003E neutral polysaccharide composed of galactose, N-acetyl-glucosamine, and N-acetyl-mannosamine (\u003Cem\u003E\u003Ca id=\u0022xref-ref-18-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-18\u0022\u003E18\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-20-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E\u003C\/em\u003E). Well-characterized \u003Cem\u003EB. anthracis\u003C\/em\u003E-specific endolysins, such as PlyB (\u003Cem\u003E\u003Ca id=\u0022xref-ref-21-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-21\u0022\u003E21\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-22-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E\u003C\/em\u003E), PlyL (\u003Cem\u003E\u003Ca id=\u0022xref-ref-18-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-18\u0022\u003E18\u003C\/a\u003E\u003C\/em\u003E), and PlyG (\u003Cem\u003E\u003Ca id=\u0022xref-ref-18-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-18\u0022\u003E18\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-20-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-23-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-23\u0022\u003E23\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-27-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-27\u0022\u003E27\u003C\/a\u003E\u003C\/em\u003E), bind to and lyse \u003Cem\u003EB. anthracis in vitro\u003C\/em\u003E and \u003Cem\u003Ein vivo.\u003C\/em\u003E Unlike \u003Cem\u003EB. anthracis\u003C\/em\u003E targeting endolysins, the surface epitope for endolysins that target \u003Cem\u003EC. difficile\u003C\/em\u003E remains unknown. Nonetheless, of the half dozen studied endolysins that target \u003Cem\u003EC. difficile,\u003C\/em\u003E all possess specificity towards \u003Cem\u003EC. difficile\u003C\/em\u003E with little to no binding observed in other bacterial species (\u003Cem\u003E\u003Ca id=\u0022xref-ref-28-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-28\u0022\u003E28\u003C\/a\u003E\u003C\/em\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-20\u0022\u003EIn the present study, the species-specificity of endolysin CWTs is harnessed to drive anti-toxin IgGs to the surface of \u003Cem\u003EB. anthracis\u003C\/em\u003E or \u003Cem\u003EC. difficile\u003C\/em\u003E bacteria. Engineered chimeras of well-defined and validated toxin-specific mAbs (W2, M18, and AVP-21D9 for \u003Cem\u003EB. anthracis\u003C\/em\u003E, and anti-TcdA (6G5) and anti-TcdB (9H10) for \u003Cem\u003EC. difficile\u003C\/em\u003E) were generated by fusing the C-termini of their heavy chains(HC) with either \u003Cem\u003EB. anthracis\u003C\/em\u003E-specific or \u003Cem\u003EC. difficile\u003C\/em\u003E-specific endolysin CWTs (PlyB, PlyG, and PlyL for \u003Cem\u003EB. anthracis\u003C\/em\u003E, and 630A and CCL2 for \u003Cem\u003EC. difficile\u003C\/em\u003E) (\u003Ca id=\u0022xref-fig-1-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig. 1A\u003C\/a\u003E), creating various ISTAbs (\u003Ca id=\u0022xref-fig-1-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig. 1B\u003C\/a\u003E). As shown in \u003Ca id=\u0022xref-fig-1-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig.1C\u003C\/a\u003E, ISTAbs are expected to bind to the bacterial cell wall, capturing the released toxins and inducing clearance of the bacteria-toxin complex by neutrophils. Candidate ISTAbs were evaluated for the ability to target IgGs directly to the bacterial surface via the CWT domain and benchmarked against parental IgGs to demonstrate retained binding to toxin, toxin neutralization activity, binding to Fc\u03b3R, and promotion of OPK against \u003Cem\u003EB. anthracis\u003C\/em\u003E. The efficacy of lead ISTAbs in comparison to parental IgGs against both pre- and post-\u003Cem\u003EB. anthracis\u003C\/em\u003E challenge was evaluated in the mouse model of anthrax. ISTAb efficacy was also evaluated using the non-human primate (NHP) aerosol model of anthrax. Furthermore, for \u003Cem\u003EC. difficile\u003C\/em\u003E, the \u003Cem\u003Ein vivo\u003C\/em\u003E efficacy of lead ISTAb compared to parental IgG was evaluated using the hamster challenge model. In summary, data presented here establish the proof-of-principle for a novel immunotherapeutic concept that should prove applicable to a wide range of toxin-driven bacterial infections.\u003C\/p\u003E\u003Cdiv id=\u0022F1\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F1.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022ISTAb Technology. (A) Cartoon showing phage-derived bacteriolysin protein with N-terminal domain, catalytic domain and cell wall targeting (CWT) domains. (B) Cartoon showing an ISTAb construct. A species-specific cell surface binding region CWT is fused to a monoclonal anti-toxin IgG via a linker sequence. (C) Diagrammatic representation of ISTAbs purposed ability to neutralize toxin and prevent toxemia, tissue destruction and immune evasion. Also, its ability to clear bacterial-immune complex via opsonophagocytic killing.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1518606228\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;ISTAb Technology.\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;(A)\u0026lt;\/strong\u0026gt; Cartoon showing phage-derived bacteriolysin protein with N-terminal domain, catalytic domain and cell wall targeting (CWT) domains. \u0026lt;strong\u0026gt;(B)\u0026lt;\/strong\u0026gt; Cartoon showing an ISTAb construct. A species-specific cell surface binding region CWT is fused to a monoclonal anti-toxin IgG via a linker sequence. \u0026lt;strong\u0026gt;(C)\u0026lt;\/strong\u0026gt; Diagrammatic representation of ISTAbs purposed ability to neutralize toxin and prevent toxemia, tissue destruction and immune evasion. Also, its ability to clear bacterial-immune complex via opsonophagocytic killing.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Fig. 1:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F1.medium.gif\u0022 width=\u0022440\u0022 height=\u0022205\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Fig. 1:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F1.medium.gif\u0022 width=\u0022440\u0022 height=\u0022205\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F1.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Fig. 1:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F1.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFig. 1:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EISTAb Technology.\u003C\/span\u003E\u003Cp id=\u0022p-21\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003E(A)\u003C\/strong\u003E Cartoon showing phage-derived bacteriolysin protein with N-terminal domain, catalytic domain and cell wall targeting (CWT) domains. \u003Cstrong\u003E(B)\u003C\/strong\u003E Cartoon showing an ISTAb construct. A species-specific cell surface binding region CWT is fused to a monoclonal anti-toxin IgG via a linker sequence. \u003Cstrong\u003E(C)\u003C\/strong\u003E Diagrammatic representation of ISTAbs purposed ability to neutralize toxin and prevent toxemia, tissue destruction and immune evasion. Also, its ability to clear bacterial-immune complex via opsonophagocytic killing.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-2\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EResults\u003C\/h2\u003E\u003Cdiv id=\u0022sec-3\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EIdentification of CWTs for ISTAb construction\u003C\/h3\u003E\u003Cp id=\u0022p-22\u0022\u003EThe \u03b3 phage has been used by the CDC for many years as a diagnostic for anthrax because it specifically lyses \u003Cem\u003EB. anthracis\u003C\/em\u003E with no activity against non-\u003Cem\u003EB. anthracis\u003C\/em\u003E strains, except for \u003Cem\u003EBacillus cereus\u003C\/em\u003E 4342, a \u003Cem\u003EB. anthracis\u003C\/em\u003E transition state strain (\u003Cem\u003E\u003Ca id=\u0022xref-ref-20-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E\u003C\/em\u003E). Significantly, the \u03b3 phage and its endolysin, PlyG, share the same host range. The specificity of PlyG is dictated by its CWT domain, a lectin-like binding domain that recognizes \u003Cem\u003EB. anthracis\u003C\/em\u003E (\u003Cem\u003E\u003Ca id=\u0022xref-ref-18-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-18\u0022\u003E18\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-20-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E\u003C\/em\u003E). In order to identify \u003Cem\u003EB. anthracis-\u003C\/em\u003Especific binding proteins similar to PlyG CWT, we performed a bioinformatic analysis on CWT domains of all endolysins contained in sequenced \u003Cem\u003EB. anthracis\u003C\/em\u003E phage and of autolysins of \u003Cem\u003EB. anthracis\u003C\/em\u003E strains. The analysis revealed 10 endolysin CWT families containing the archetypical endolysins PlyG, PlyPH, PlyCherry, PlyWBeta, AmiBA2446, PlyL, PlyAP50, PlyTsamsa, PlyB, and PlyBeta. However, several of these endolysins shared high sequence identity (84-99%), narrowing our search down to five unique CWTs with lower sequence identity (range 12-66%) (\u003Ca id=\u0022xref-fig-2-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig 2A\u003C\/a\u003E). All five \u003Cem\u003EB. anthracis\u003C\/em\u003E CWTs were recombinantly expressed in \u003Cem\u003EE. coli\u003C\/em\u003E and purified. The PlyL- and PlyG-CWTs were expressed with high yields, whereas those of PlyTsamsa and PlyB had very low yields, and PlyAP50 did not fold properly. Thus, PlyL, PlyG along with PlyB were promoted as \u201cfinalist\u201d CWTs for further evaluation against a panel of \u003Cem\u003EBacillus\u003C\/em\u003E species. PlyL and PlyG bound to \u003Cem\u003EB. cereus\u003C\/em\u003E 4342, a transition state strain, four attenuated (BSL2) \u003Cem\u003EB. anthracis\u003C\/em\u003E strains (Ames35, UM23, Sterne, and \u0394Sterne), and two fully virulent (BSL3) \u003Cem\u003EB. anthracis\u003C\/em\u003E strains (Ames and ASC506), but not to other \u003Cem\u003EBacillus\u003C\/em\u003E species including other \u003Cem\u003EB. cereus\u003C\/em\u003E species, confirming the high binding specificity of the CWTs for \u003Cem\u003EB. anthracis\u003C\/em\u003E (\u003Ca id=\u0022xref-fig-2-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2B\u003C\/a\u003E). None of the \u003Cem\u003EB. anthracis\u003C\/em\u003E strains displayed any autofluorescence, validating that any observed fluorescence signal is the result of CWT binding (\u003Ca id=\u0022xref-fig-2-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2C\u003C\/a\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022F2\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F2.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Characterization of endolysin CWTs. (A) Sequence homology of five unique B. anthracis endolysin CWTs. (B) Binding results for PlyL and PlyG CWTs tested against a panel of B. anthracis species. (C) Fluorescence microscopy image of Alexa Fluor-labeled PlyL and PlyG CWT binding to BSL2 strains (Sterne and \u0026#x394;Sterne) and BSL3 strains (Ames and ASC506) of B. anthracis.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1518606228\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Characterization of endolysin CWTs.\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;(A)\u0026lt;\/strong\u0026gt; Sequence homology of five unique \u0026lt;em\u0026gt;B. anthracis\u0026lt;\/em\u0026gt; endolysin CWTs. \u0026lt;strong\u0026gt;(B)\u0026lt;\/strong\u0026gt; Binding results for PlyL and PlyG CWTs tested against a panel of \u0026lt;em\u0026gt;B. anthracis\u0026lt;\/em\u0026gt; species. \u0026lt;strong\u0026gt;(C)\u0026lt;\/strong\u0026gt; Fluorescence microscopy image of Alexa Fluor-labeled PlyL and PlyG CWT binding to BSL2 strains (Sterne and \u0026#x394;Sterne) and BSL3 strains (Ames and ASC506) of \u0026lt;em\u0026gt;B. anthracis\u0026lt;\/em\u0026gt;.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Fig. 2:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F2.medium.gif\u0022 width=\u0022440\u0022 height=\u0022287\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Fig. 2:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F2.medium.gif\u0022 width=\u0022440\u0022 height=\u0022287\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F2.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Fig. 2:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F2.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFig. 2:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003ECharacterization of endolysin CWTs.\u003C\/span\u003E\u003Cp id=\u0022p-23\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003E(A)\u003C\/strong\u003E Sequence homology of five unique \u003Cem\u003EB. anthracis\u003C\/em\u003E endolysin CWTs. \u003Cstrong\u003E(B)\u003C\/strong\u003E Binding results for PlyL and PlyG CWTs tested against a panel of \u003Cem\u003EB. anthracis\u003C\/em\u003E species. \u003Cstrong\u003E(C)\u003C\/strong\u003E Fluorescence microscopy image of Alexa Fluor-labeled PlyL and PlyG CWT binding to BSL2 strains (Sterne and \u0394Sterne) and BSL3 strains (Ames and ASC506) of \u003Cem\u003EB. anthracis\u003C\/em\u003E.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-4\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EConstruction, purification, and characterization of ISTAbs\u003C\/h3\u003E\u003Cp id=\u0022p-24\u0022\u003EThe mAbs M18, W2, and AVP-21D9 (all IgG1) were selected as the scaffolds for the construction of \u003Cem\u003EB. anthracis\u003C\/em\u003E ISTAbs. M18 binds PA with high affinity (\u003Cem\u003EK\u003C\/em\u003E\u003Csub\u003ED\u003C\/sub\u003E of 35 pM) (\u003Cem\u003E\u003Ca id=\u0022xref-ref-29-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-29\u0022\u003E29\u003C\/a\u003E\u003C\/em\u003E), neutralizes the activity of both the lethal toxin \u003Cem\u003Ein vivo\u003C\/em\u003E (Fischer 344 rat model) and the edema toxin \u003Cem\u003Ein vitro\u003C\/em\u003E (CHO cells) (\u003Cem\u003E\u003Ca id=\u0022xref-ref-30-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-30\u0022\u003E30\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-31-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-31\u0022\u003E31\u003C\/a\u003E\u003C\/em\u003E), and blocks the binding of PA to fetal Rhesus lung cells (FRL-103) (\u003Cem\u003E\u003Ca id=\u0022xref-ref-9-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-9\u0022\u003E9\u003C\/a\u003E\u003C\/em\u003E). W2, a highly neutralizing chimpanzee-derived mAb, binds PA with a \u003Cem\u003EK\u003C\/em\u003E\u003Csub\u003ED\u003C\/sub\u003E of 40 pM and neutralizes the cytotoxicity of the lethal toxin in a macrophage lysis assay (\u003Cem\u003E\u003Ca id=\u0022xref-ref-32-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-32\u0022\u003E32\u003C\/a\u003E\u003C\/em\u003E). AVP-21D9 is a well-characterized human PA neutralizing mAb that provided up to 92% and 67% survival in rabbits and macaques, respectively, against anthrax challenge. Infusion of AVP-21D9 (10 mg\/kg) is well tolerated in healthy adults (\u003Cem\u003E\u003Ca id=\u0022xref-ref-33-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-33\u0022\u003E33\u003C\/a\u003E\u003C\/em\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-25\u0022\u003EThe HC of each antibody (M18, W2, and AVP-21D9) was fused with a \u003Cem\u003EB. anthracis\u003C\/em\u003E specific CWT (PlyB, PlyG, or PlyL) and co-expressed with the respective light chain to generate nine different ISTAbs along with their parental IgG. As shown in \u003Ca id=\u0022xref-fig-3-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3A\u003C\/a\u003E, the HC of each ISTAb showed the anticipated larger molecular weight band compared to the parental IgG and exhibited no notable degradation. Using differential scanning fluorimetry (DSF), we evaluated whether the CWTs altered the thermal stability of ISTAbs. Towards this end, we calculated the average melting temperatures (T\u003Csub\u003Em\u003C\/sub\u003E) using a thermocycler-based method wherein the SYPRO-orange dye binds preferentially to hydrophobic patches that are exposed as the proteins unfold with increasing temperature (\u003Ca id=\u0022xref-fig-3-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3B\u003C\/a\u003E, Supplemental Table S1). M18 IgG and M18-PlyB ISTAb exhibited a T\u003Csub\u003Em\u003C\/sub\u003E of 68.5\u00b10.5\u2103 and 55.5\u00b10\u2103, respectively, corresponding to a thermal shift of 13\u2103, while addition of the PlyL or PlyG CWTs to M18 minimally reduced the Tm (\u0026lt;2\u2103). Similarly, W2-PlyB showed a modest reduction in thermal stability (2.7\u2103). Addition of PlyL or PlyG-CWTs did not have any significant effect on W2 (Supplemental Table S1) or AVP-21D9 stability (\u003Ca id=\u0022xref-fig-3-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3B\u003C\/a\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022F3\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F3.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Characterization of ISTAbs. (A) SDS-PAGE analysis of ISTAbs and parental IgGs. MW designates molecular weight markers. Positions of IgG and ISTAb are indicated by arrows. Each protein was run in two different concentrations: 1 and 5 \u0026#xB5;g per lane (as labeled in the first two lanes). (B) Thermal unfolding profile of AVP-21D9 IgG and its ISTAbs indicating equivalent thermal stability. (C) ELISA measurement of dose-dependent binding of AVP-21D9 and its ISTAb derivatives to PA. (D) EC50 (ng\/ml) table for PA binding of nine ISTAbs and three parental IgGs. (E) Whole-cell ELISA for binding to B. anthracis strain UM23. Detection was with anti-human IgG conjugate. (F) EC50 (\u0026#xB5;g\/ml) table summarizing the binding abilities of the nine ISTAbs and three parental IgGs to B. anthracis UM23 strain. (G) The ability of candidate ISTAbs to bind attenuated B. anthracis strains (BSL2) was analyzed by immunofluorescence microscopy and qualitative data are shown (top). Fluorescent images (bottom) show examples of parental IgG versus ISTAb binding for W2 and AVP-21D9. (H) ISTAb binding to B. anthracis Ames strain (BSL3) is shown. B. anthracis bacteria were incubated with each ISTAb to allow binding and were visualized by fluorescent microscopy after the addition of a secondary antibody against the ISTAb. Phase contrast (top) and fluorescent images (bottom) are shown. (I) CellTiter Glo assay of dose-dependent toxicity of 160 nM LF combined with PA toxin. (J) Anthrax toxin neutralization by AVP-21D9 ISTAbs and parental IgG. (K) NT50 values in \u0026#xB5;g\/ml for the three IgGs and their nine corresponding ISTAbs.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1518606228\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Characterization of ISTAbs.\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;(A)\u0026lt;\/strong\u0026gt; SDS-PAGE analysis of ISTAbs and parental IgGs. MW designates molecular weight markers. Positions of IgG and ISTAb are indicated by arrows. Each protein was run in two different concentrations: 1 and 5 \u0026#xB5;g per lane (as labeled in the first two lanes). \u0026lt;strong\u0026gt;(B)\u0026lt;\/strong\u0026gt; Thermal unfolding profile of AVP-21D9 IgG and its ISTAbs indicating equivalent thermal stability. \u0026lt;strong\u0026gt;(C)\u0026lt;\/strong\u0026gt; ELISA measurement of dose-dependent binding of AVP-21D9 and its ISTAb derivatives to PA. \u0026lt;strong\u0026gt;(D)\u0026lt;\/strong\u0026gt; EC\u0026lt;sub\u0026gt;50\u0026lt;\/sub\u0026gt; (ng\/ml) table for PA binding of nine ISTAbs and three parental IgGs. \u0026lt;strong\u0026gt;(E)\u0026lt;\/strong\u0026gt; Whole-cell ELISA for binding to \u0026lt;em\u0026gt;B. anthracis\u0026lt;\/em\u0026gt; strain UM23. Detection was with anti-human IgG conjugate. \u0026lt;strong\u0026gt;(F)\u0026lt;\/strong\u0026gt; EC\u0026lt;sub\u0026gt;50\u0026lt;\/sub\u0026gt; (\u0026#xB5;g\/ml) table summarizing the binding abilities of the nine ISTAbs and three parental IgGs to \u0026lt;em\u0026gt;B. anthracis\u0026lt;\/em\u0026gt; UM23 strain. \u0026lt;strong\u0026gt;(G)\u0026lt;\/strong\u0026gt; The ability of candidate ISTAbs to bind attenuated B. anthracis strains (BSL2) was analyzed by immunofluorescence microscopy and qualitative data are shown (top). Fluorescent images (bottom) show examples of parental IgG versus ISTAb binding for W2 and AVP-21D9. \u0026lt;strong\u0026gt;(H)\u0026lt;\/strong\u0026gt; ISTAb binding to \u0026lt;em\u0026gt;B. anthracis\u0026lt;\/em\u0026gt; Ames strain (BSL3) is shown. \u0026lt;em\u0026gt;B. anthracis\u0026lt;\/em\u0026gt; bacteria were incubated with each ISTAb to allow binding and were visualized by fluorescent microscopy after the addition of a secondary antibody against the ISTAb. Phase contrast (top) and fluorescent images (bottom) are shown. \u0026lt;strong\u0026gt;(I)\u0026lt;\/strong\u0026gt; CellTiter Glo assay of dose-dependent toxicity of 160 nM LF combined with PA toxin. \u0026lt;strong\u0026gt;(J)\u0026lt;\/strong\u0026gt; Anthrax toxin neutralization by AVP-21D9 ISTAbs and parental IgG. \u0026lt;strong\u0026gt;(K)\u0026lt;\/strong\u0026gt; NT\u0026lt;sub\u0026gt;50\u0026lt;\/sub\u0026gt; values in \u0026#xB5;g\/ml for the three IgGs and their nine corresponding ISTAbs.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Fig. 3:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F3.medium.gif\u0022 width=\u0022440\u0022 height=\u0022198\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Fig. 3:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F3.medium.gif\u0022 width=\u0022440\u0022 height=\u0022198\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F3.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Fig. 3:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F3.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFig. 3:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003ECharacterization of ISTAbs.\u003C\/span\u003E\u003Cp id=\u0022p-26\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003E(A)\u003C\/strong\u003E SDS-PAGE analysis of ISTAbs and parental IgGs. MW designates molecular weight markers. Positions of IgG and ISTAb are indicated by arrows. Each protein was run in two different concentrations: 1 and 5 \u00b5g per lane (as labeled in the first two lanes). \u003Cstrong\u003E(B)\u003C\/strong\u003E Thermal unfolding profile of AVP-21D9 IgG and its ISTAbs indicating equivalent thermal stability. \u003Cstrong\u003E(C)\u003C\/strong\u003E ELISA measurement of dose-dependent binding of AVP-21D9 and its ISTAb derivatives to PA. \u003Cstrong\u003E(D)\u003C\/strong\u003E EC\u003Csub\u003E50\u003C\/sub\u003E (ng\/ml) table for PA binding of nine ISTAbs and three parental IgGs. \u003Cstrong\u003E(E)\u003C\/strong\u003E Whole-cell ELISA for binding to \u003Cem\u003EB. anthracis\u003C\/em\u003E strain UM23. Detection was with anti-human IgG conjugate. \u003Cstrong\u003E(F)\u003C\/strong\u003E EC\u003Csub\u003E50\u003C\/sub\u003E (\u00b5g\/ml) table summarizing the binding abilities of the nine ISTAbs and three parental IgGs to \u003Cem\u003EB. anthracis\u003C\/em\u003E UM23 strain. \u003Cstrong\u003E(G)\u003C\/strong\u003E The ability of candidate ISTAbs to bind attenuated B. anthracis strains (BSL2) was analyzed by immunofluorescence microscopy and qualitative data are shown (top). Fluorescent images (bottom) show examples of parental IgG versus ISTAb binding for W2 and AVP-21D9. \u003Cstrong\u003E(H)\u003C\/strong\u003E ISTAb binding to \u003Cem\u003EB. anthracis\u003C\/em\u003E Ames strain (BSL3) is shown. \u003Cem\u003EB. anthracis\u003C\/em\u003E bacteria were incubated with each ISTAb to allow binding and were visualized by fluorescent microscopy after the addition of a secondary antibody against the ISTAb. Phase contrast (top) and fluorescent images (bottom) are shown. \u003Cstrong\u003E(I)\u003C\/strong\u003E CellTiter Glo assay of dose-dependent toxicity of 160 nM LF combined with PA toxin. \u003Cstrong\u003E(J)\u003C\/strong\u003E Anthrax toxin neutralization by AVP-21D9 ISTAbs and parental IgG. \u003Cstrong\u003E(K)\u003C\/strong\u003E NT\u003Csub\u003E50\u003C\/sub\u003E values in \u00b5g\/ml for the three IgGs and their nine corresponding ISTAbs.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-5\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EISTAb and parental IgG binding to PA and B. anthracis\u003C\/h3\u003E\u003Cp id=\u0022p-27\u0022\u003EWe performed ELISA to measure binding of the nine ISTAbs and the parental IgGs to PA and to whole bacterial cells. Except for AVP-21D9-PlyB, binding of ISTAbs and parental IgGs to PA were indistinguishable, indicating that the CWT did not affect antigen binding (\u003Ca id=\u0022xref-fig-3-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3C\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-3-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003ED\u003C\/a\u003E). As expected, parental IgGs did not bind to the surface of \u003Cem\u003EB. anthracis\u003C\/em\u003E (\u003Ca id=\u0022xref-fig-3-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3E\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-3-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EF\u003C\/a\u003E). All three ISTAbs containing the PlyG CWT bound the \u003Cem\u003EB. anthracis\u003C\/em\u003E surface in whole cell ELISA, whereas ISTAbs containing PlyB or PlyL CWTs showed high EC\u003Csub\u003E50\u003C\/sub\u003E (\u0026gt;200 \u00b5g\/ml) in this assay (\u003Ca id=\u0022xref-fig-3-8\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3F\u003C\/a\u003E). These data confirm that both Fab and CWTs are functional in the PlyG-based ISTAbs.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-6\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EMicroscopic visualization of ISTAb binding to the bacterial surface\u003C\/h3\u003E\u003Cp id=\u0022p-28\u0022\u003EAll nine \u003Cem\u003EB. anthracis\u003C\/em\u003E ISTAbs were evaluated for binding to the bacterial surface, utilizing an AlexaFluor 488-labeled mouse anti-human IgG1 Fc secondary antibody for microscopic visualization. The AVP-21D9 based ISTAbs bound attenuated (BSL-2) strains of \u003Cem\u003EB. anthracis\u003C\/em\u003E UM23 and Ames35 regardless of the origin of the CWT domain (\u003Ca id=\u0022xref-fig-3-9\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3G\u003C\/a\u003E). In contrast, the W2-based ISTAb did not bind UM23 or Ames35 strains when the PlyB CWT was utilized, and the only M18-based ISTAb that bound \u003Cem\u003EB. anthracis\u003C\/em\u003E contained the PlyG CWT. Taken together, the PlyG CWT is clearly the best candidate for construction of ISTAbs as it bound both \u003Cem\u003EB. anthracis\u003C\/em\u003E UM23 and Ames35 strains with all three mAb scaffolds. Similarly, when ISTAbs were tested against the fully virulent Ames strain of \u003Cem\u003EB. anthracis\u003C\/em\u003E, the parental IgGs did not show any binding whereas the PlyG CWT-based ISTAbs showed the strongest binding (\u003Ca id=\u0022xref-fig-3-10\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3H\u003C\/a\u003E). Importantly, the lead ISTAb candidate (AVP-21D9-PlyG) also binds capsulated \u003Cem\u003EB. anthracis\u003C\/em\u003E Ames strain (Fig. S1), indicating that the capsule does not interfere with the function of ISTAbs.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-7\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EB. anthracis ISTAb toxin neutralization and binding affinities\u003C\/h3\u003E\u003Cp id=\u0022p-29\u0022\u003EWe next determined whether ISTAbs retain the neutralizing activity of the parental antibody using a cell viability assay in presence of purified anthrax toxin (\u003Ca id=\u0022xref-fig-3-11\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3I\u003C\/a\u003E). Dose response toxin neutralization plots for AVP-21D9 and its respective ISTAbs demonstrate that the ISTAbs retained neutralization activity similar to parental IgGs (\u003Ca id=\u0022xref-fig-3-12\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3J\u003C\/a\u003E), with AVP-21D9-derived ISTAbs exhibiting \u0026gt;10 times better neutralization than M18 or W2 ISTAbs (\u003Ca id=\u0022xref-fig-3-13\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3K\u003C\/a\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-30\u0022\u003EWe also measured the affinity of PlyG-containing ISTAbs for PA using Biolayer Interferometry (Fig. S2A-D). The apparent \u003Cem\u003EK\u003Csub\u003ED\u003C\/sub\u003E\u003C\/em\u003E values for W2, W2-PlyG, AVP-21D9, and AVP-21D9-PlyG binding to PA were 0.5, 0.6, 0.001, and 0.06 nM, respectively. The reduction in the affinity of AVP-21D9-PlyG compared to parental IgG was a result of faster off-rate; however, the ISTAb still maintained picomolar affinity for PA (\u003Ca id=\u0022xref-table-wrap-1-1\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable 1\u003C\/a\u003E, Fig. S2A-D), consistent with the neutralizing activity (\u003Ca id=\u0022xref-fig-3-14\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3J\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-3-15\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EK\u003C\/a\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022T1\u0022 class=\u0022table pos-float\u0022\u003E\u003Cdiv class=\u0022table-inline table-callout-links\u0022\u003E\u003Cdiv class=\u0022callout\u0022\u003E\u003Cspan\u003EView this table:\u003C\/span\u003E\u003Cul class=\u0022callout-links\u0022\u003E\u003Cli class=\u0022view-inline first\u0022\u003E\u003Ca href=\u0022\u0022 class=\u0022table-expand-inline\u0022 data-table-url=\u0022\/highwire\/markup\/874003\/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0026amp;table-expand-inline=1\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView inline\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022view-popup\u0022\u003E\u003Ca href=\u0022\/highwire\/markup\/874003\/expansion?width=1000\u0026amp;height=500\u0026amp;iframe=true\u0026amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0022 class=\u0022colorbox colorbox-load table-expand-popup\u0022 rel=\u0022gallery-fragment-tables\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView popup\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022download-ppt last\u0022\u003E\u003Ca href=\u0022\/highwire\/powerpoint\/874003\u0022 class=\u0022highwire-figure-link highwire-figure-link-ppt\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload powerpoint\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022table-caption\u0022\u003E\u003Cspan class=\u0022table-label\u0022\u003ETable 1.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EA summary of \u003Cem\u003EK\u003C\/em\u003E\u003Csub\u003ED\u003C\/sub\u003E values for binding to PA\u003C\/span\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-8\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EBinding to Fc\u03b3 receptors\u003C\/h3\u003E\u003Cp id=\u0022p-31\u0022\u003ETo ensure that fusion of IgG with the PlyG CWT did not interfere with FcR binding on the surface of innate immune cells, we measured the binding affinity of AVP-21D9 versus the derivative PlyG ISTAb for multiple Fc\u03b3R proteins. Both AVP-21D9 and the PlyG ISTAb showed strong binding to Fc\u03b3R1A, Fc\u03b3R2A, Fc\u03b3R2B, and FcRN (\u003Ca id=\u0022xref-fig-4-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4A\u003C\/a\u003E; Supplemental Table S2 and S3). There was no notable difference in the binding affinities of different FcR proteins for AVP-21D9 compared to AVP-21D9-PlyG. These data clearly indicate that the CWTs in the ISTAb fusion protein do not interfere with the Fc\u03b3R binding, similar to our findings for PA binding.\u003C\/p\u003E\u003Cdiv id=\u0022F4\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F4.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Binding to Fc\u0026#x3B3; receptors, OPK, Immunogenicity, and seroprevalence studies of ISTAbs. (A) Dissociation constants for binding of AVP-21D9 and AVP-21D9-PlyG to various Fc\u0026#x3B3; receptors. Each bar represents an average of three independent experiments. (B) Opsonophagocytic activities of AVP-21D9 versus AVP-21D9-PlyG at 100, 50, and 25 \u0026#xB5;g\/ml using HL-60 cells. Columns represent the average values at a 95% confidence interval (CI) for 33 data points from four independent experiments. (C) Immunogenicity measurement of CWT domain of ISTAb derivatives of M18, W2, and AVP-21D9 in comparison with respective IgGs as determined by ELISA, using plates coated with isolated PlyG domain. Samples were run in duplicate. (D) Seroprevalence of isolated PlyL and PlyG CWT domains among healthy humans. The reactivity of 88 human sera from healthy donors was tested by ELISA at 1:300 dilution. S. aureus Hla was used as a control antigen. Data were analyzed by unpaired Student\u0026#x2019;s t-test.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1518606228\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Binding to Fc\u0026#x3B3; receptors, OPK, Immunogenicity, and seroprevalence studies of ISTAbs.\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;(A)\u0026lt;\/strong\u0026gt; Dissociation constants for binding of AVP-21D9 and AVP-21D9-PlyG to various Fc\u0026#x3B3; receptors. Each bar represents an average of three independent experiments. \u0026lt;strong\u0026gt;(B)\u0026lt;\/strong\u0026gt; Opsonophagocytic activities of AVP-21D9 versus AVP-21D9-PlyG at 100, 50, and 25 \u0026#xB5;g\/ml using HL-60 cells. Columns represent the average values at a 95% confidence interval (CI) for 33 data points from four independent experiments. \u0026lt;strong\u0026gt;(C)\u0026lt;\/strong\u0026gt; Immunogenicity measurement of CWT domain of ISTAb derivatives of M18, W2, and AVP-21D9 in comparison with respective IgGs as determined by ELISA, using plates coated with isolated PlyG domain. Samples were run in duplicate. \u0026lt;strong\u0026gt;(D)\u0026lt;\/strong\u0026gt; Seroprevalence of isolated PlyL and PlyG CWT domains among healthy humans. The reactivity of 88 human sera from healthy donors was tested by ELISA at 1:300 dilution. \u0026lt;em\u0026gt;S. aureus\u0026lt;\/em\u0026gt; Hla was used as a control antigen. Data were analyzed by unpaired Student\u0026#x2019;s t-test.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Fig. 4:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F4.medium.gif\u0022 width=\u0022440\u0022 height=\u0022316\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Fig. 4:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F4.medium.gif\u0022 width=\u0022440\u0022 height=\u0022316\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F4.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Fig. 4:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F4.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFig. 4:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EBinding to Fc\u03b3 receptors, OPK, Immunogenicity, and seroprevalence studies of ISTAbs.\u003C\/span\u003E\u003Cp id=\u0022p-32\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003E(A)\u003C\/strong\u003E Dissociation constants for binding of AVP-21D9 and AVP-21D9-PlyG to various Fc\u03b3 receptors. Each bar represents an average of three independent experiments. \u003Cstrong\u003E(B)\u003C\/strong\u003E Opsonophagocytic activities of AVP-21D9 versus AVP-21D9-PlyG at 100, 50, and 25 \u00b5g\/ml using HL-60 cells. Columns represent the average values at a 95% confidence interval (CI) for 33 data points from four independent experiments. \u003Cstrong\u003E(C)\u003C\/strong\u003E Immunogenicity measurement of CWT domain of ISTAb derivatives of M18, W2, and AVP-21D9 in comparison with respective IgGs as determined by ELISA, using plates coated with isolated PlyG domain. Samples were run in duplicate. \u003Cstrong\u003E(D)\u003C\/strong\u003E Seroprevalence of isolated PlyL and PlyG CWT domains among healthy humans. The reactivity of 88 human sera from healthy donors was tested by ELISA at 1:300 dilution. \u003Cem\u003ES. aureus\u003C\/em\u003E Hla was used as a control antigen. Data were analyzed by unpaired Student\u2019s t-test.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-9\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EB. anthracis ISTAb opsonophagocytic activities\u003C\/h3\u003E\u003Cp id=\u0022p-33\u0022\u003EWe analyzed the OPK of the AVP-21D9 versus AVP-21D9-PlyG using HL-60 cells differentiated to neutrophils. HL-60 cells were incubated with three different concentrations of AVP-21D9 or the corresponding ISTAb derivative AVP-21D9-PlyG, serum-containing complement, and \u003Cem\u003EB. anthracis\u003C\/em\u003E UM23, for 30 min at room temperature (RT) followed by 45 min at 37\u00b0C, and the bacteria were then enumerated. As shown in \u003Ca id=\u0022xref-fig-4-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4B\u003C\/a\u003E, bacterial killing was observed only with the ISTAb while bacteria displayed growth only with the parental antibody, indicating that the ISTAb can mediate opsonophagocytic activity.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-10\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EImmunogenicity towards the B. anthracis ISTAb CWT\u003C\/h3\u003E\u003Cp id=\u0022p-34\u0022\u003EAntibody responses, if elicited towards the CWT domain of ISTAbs, could potentially reduce the therapeutic efficacy. In order to examine potential immunogenicity of the PlyG CWT domain, we treated mice with PlyG-ISTAb or parental IgG for AVP-21D9, M18, and W2, and measured serum antibody titers against the PlyG CWT. As shown in \u003Ca id=\u0022xref-fig-4-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4C\u003C\/a\u003E, no significant binding was observed, indicating a lack of immunogenicity towards the PlyG CWT.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-11\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ESeroprevalence of phage CWT domains in healthy humans\u003C\/h3\u003E\u003Cp id=\u0022p-35\u0022\u003EWhile lack of immunogenicity in mice is reassuring, a potential concern for therapeutic proteins fused with a CWT would be pre-existing human antibodies to CWTs that could inactivate it by blocking CWT binding to the bacterial cell wall. To address this concern, we screened 88 healthy human plasma samples for antibody titers against CWTs for PlyL and PlyG. As a positive control, we used the staphylococcal alpha toxin (Hla), an antigen to which many people have been exposed (\u003Cem\u003E\u003Ca id=\u0022xref-ref-34-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-34\u0022\u003E34\u003C\/a\u003E\u003C\/em\u003E). As expected, we observed high titers against Hla, but nearly undetectable titers against PlyL and PlyG (\u003Ca id=\u0022xref-fig-4-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4D\u003C\/a\u003E) indicating low seroprevalence against these two CWTs.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-12\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EStability of ISTAbs\u003C\/h3\u003E\u003Cp id=\u0022p-36\u0022\u003EAVP-21D9 and AVP-21D9-PlyG were stored at 1 mg\/ml at 4\u00b0C, 25\u00b0C, or 40\u00b0C and tested after 1 month by SDS-PAGE, size exclusion HPLC, and toxin neutralization assay (TNA) to determine the structural and functional integrity of the proteins. As the SDS-PAGE and HPLC data for the 1-month time point demonstrate (Fig. S3A and B) both the parental IgG and its derivative ISTAb remained remarkably stable over the study period. The samples also retained functional activity by TNA assays (Fig. S3C). As isomerization of mAbs is a critical productibility issue, we carried out LC-MS on AVP-21D9 and AVP-21D9-PlyG stored at 40\u00b0C for 1 wk. Based on the data, no significant risk was reported for iso-Asp deamidation (Fig. S3D).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-13\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPre-challenge mouse efficacy studies for subcutaneous (s.c.) route of infection\u003C\/h3\u003E\u003Cp id=\u0022p-37\u0022\u003EWe first determined the sub-protective doses for the two parental antibodies, AVP-21D9 and W2, in order to determine a range where potential improvements by their derivative ISTAbs could be detected. Groups of five Swiss Webster mice (8 weeks old) were injected s.c. with the antibodies, or buffer control, two hours before s.c. challenge with 10LD\u003Csub\u003E50\u003C\/sub\u003E of \u003Cem\u003EB. anthracis\u003C\/em\u003E Ames. Health scores were recorded daily for 14 days. The results demonstrated 40% survival in mice that received W2 at 20 \u03bcg\/mouse or AVP-21D9 at 15 \u03bcg\/mouse respectively (\u003Ca id=\u0022xref-fig-5-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFig. 5A\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-5-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EB\u003C\/a\u003E). These partial rescue doses were selected for pre-challenge evaluation of the ISTAbs (AVP-21D9-PlyG and W2-PlyG). As above, mice were administered with the parental antibodies (AVP-21D9 at 15 \u03bcg\/mouse, or W2 at 20 \u03bcg\/mouse; n=10 per group), or an equimolar amount of the derivative ISTAbs, and challenged two hours later s.c. with 10 LD\u003Csub\u003E50\u003C\/sub\u003E \u003Cem\u003EB. anthracis\u003C\/em\u003E Ames. As shown in \u003Ca id=\u0022xref-fig-5-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFig. 5C\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-5-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003ED\u003C\/a\u003E, both ISTAbs provided a higher level of survival compared to the parental IgGs. Residual bacterial burden in the surviving animals treated with either AVP-21D9 or AVP-21D9-PlyG was also determined. While not statistically significant, perhaps due to the small number of remaining mice, a clear trend was observed toward lower bacterial burden in the liver, lungs, and spleen of the ISTAb-treated animals compared to the IgG group (\u003Ca id=\u0022xref-fig-5-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFig. 5E\u003C\/a\u003E). None of the surviving animals had detectable bacteria in their blood at the study termination.\u003C\/p\u003E\u003Cdiv id=\u0022F5\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F5.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Mouse efficacy studies. (A,B) Sub-protective dose determination for AVP-21D9 and W2 antibodies. Mice were injected with varying doses of either AVP-21D9 or W2 IgGs, or with vehicle control, prior to s.c. challenge with the Ames strain of B. anthracis. Mice were monitored daily for morbidity and mortality for a period of 14 days post-challenge. (C, D) Efficacy of the parental IgGs or their derivative ISTAbs delivered two hours before s.c. infection with Ames spores. Statistical analysis was performed using the Log-rank (Mantel-Cox) method. (E) Quantitation of remaining bacterial load (CFU\/g) in liver, lung, and spleen of surviving mice from the pre-exposure studies. (F) Efficacy of 330 \u0026#xB5;g\/mouse of AVP-21D9, or a molar equivalent amount of its derivative ISTAb (AVP-21D9-PlyG), delivered 18-24h post-infection with Ames spores using the s.c. route of challenge. Statistical analysis was performed using the Log-rank (Mantel-Cox) method. (G) Quantitation of remaining bacterial load (CFU\/g) in liver, lung, and spleen of surviving mice from the post-exposure studies on day 14 post-challenge. (H) Pre-challenge mouse efficacy of AVP-21D9 and AVP-21D9-PlyG in respiratory infection model of anthrax. (I) Post-challenge mouse efficacy of AVP-21D9 and AVP-21D9-PlyG in respiratory infection model of anthrax. Mice were challenged intranasally with the Ames strain and 48 hours post-challenge were treated via the IP route with either AVP-21D9 (195 \u0026#xB5;g\/mouse) or the molar equivalent of AVP-21D9-PlyG (216 ug\/mouse), or with vehicle control. Mice were monitored daily for morbidity and mortality for a period of 20 days post-challenge.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1518606228\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Mouse efficacy studies.\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;(A,B)\u0026lt;\/strong\u0026gt; Sub-protective dose determination for AVP-21D9 and W2 antibodies. Mice were injected with varying doses of either AVP-21D9 or W2 IgGs, or with vehicle control, prior to s.c. challenge with the Ames strain of \u0026lt;em\u0026gt;B. anthracis\u0026lt;\/em\u0026gt;. Mice were monitored daily for morbidity and mortality for a period of 14 days post-challenge. \u0026lt;strong\u0026gt;(C, D)\u0026lt;\/strong\u0026gt; Efficacy of the parental IgGs or their derivative ISTAbs delivered two hours before s.c. infection with Ames spores. Statistical analysis was performed using the Log-rank (Mantel-Cox) method. \u0026lt;strong\u0026gt;(E)\u0026lt;\/strong\u0026gt; Quantitation of remaining bacterial load (CFU\/g) in liver, lung, and spleen of surviving mice from the pre-exposure studies. \u0026lt;strong\u0026gt;(F)\u0026lt;\/strong\u0026gt; Efficacy of 330 \u0026#xB5;g\/mouse of AVP-21D9, or a molar equivalent amount of its derivative ISTAb (AVP-21D9-PlyG), delivered 18-24h post-infection with Ames spores using the s.c. route of challenge. Statistical analysis was performed using the Log-rank (Mantel-Cox) method. \u0026lt;strong\u0026gt;(G)\u0026lt;\/strong\u0026gt; Quantitation of remaining bacterial load (CFU\/g) in liver, lung, and spleen of surviving mice from the post-exposure studies on day 14 post-challenge. \u0026lt;strong\u0026gt;(H)\u0026lt;\/strong\u0026gt; Pre-challenge mouse efficacy of AVP-21D9 and AVP-21D9-PlyG in respiratory infection model of anthrax. \u0026lt;strong\u0026gt;(I)\u0026lt;\/strong\u0026gt; Post-challenge mouse efficacy of AVP-21D9 and AVP-21D9-PlyG in respiratory infection model of anthrax. Mice were challenged intranasally with the Ames strain and 48 hours post-challenge were treated via the IP route with either AVP-21D9 (195 \u0026#xB5;g\/mouse) or the molar equivalent of AVP-21D9-PlyG (216 ug\/mouse), or with vehicle control. Mice were monitored daily for morbidity and mortality for a period of 20 days post-challenge.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Fig. 5:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F5.medium.gif\u0022 width=\u0022440\u0022 height=\u0022199\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Fig. 5:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F5.medium.gif\u0022 width=\u0022440\u0022 height=\u0022199\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F5.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Fig. 5:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F5.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFig. 5:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EMouse efficacy studies.\u003C\/span\u003E\u003Cp id=\u0022p-38\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003E(A,B)\u003C\/strong\u003E Sub-protective dose determination for AVP-21D9 and W2 antibodies. Mice were injected with varying doses of either AVP-21D9 or W2 IgGs, or with vehicle control, prior to s.c. challenge with the Ames strain of \u003Cem\u003EB. anthracis\u003C\/em\u003E. Mice were monitored daily for morbidity and mortality for a period of 14 days post-challenge. \u003Cstrong\u003E(C, D)\u003C\/strong\u003E Efficacy of the parental IgGs or their derivative ISTAbs delivered two hours before s.c. infection with Ames spores. Statistical analysis was performed using the Log-rank (Mantel-Cox) method. \u003Cstrong\u003E(E)\u003C\/strong\u003E Quantitation of remaining bacterial load (CFU\/g) in liver, lung, and spleen of surviving mice from the pre-exposure studies. \u003Cstrong\u003E(F)\u003C\/strong\u003E Efficacy of 330 \u00b5g\/mouse of AVP-21D9, or a molar equivalent amount of its derivative ISTAb (AVP-21D9-PlyG), delivered 18-24h post-infection with Ames spores using the s.c. route of challenge. Statistical analysis was performed using the Log-rank (Mantel-Cox) method. \u003Cstrong\u003E(G)\u003C\/strong\u003E Quantitation of remaining bacterial load (CFU\/g) in liver, lung, and spleen of surviving mice from the post-exposure studies on day 14 post-challenge. \u003Cstrong\u003E(H)\u003C\/strong\u003E Pre-challenge mouse efficacy of AVP-21D9 and AVP-21D9-PlyG in respiratory infection model of anthrax. \u003Cstrong\u003E(I)\u003C\/strong\u003E Post-challenge mouse efficacy of AVP-21D9 and AVP-21D9-PlyG in respiratory infection model of anthrax. Mice were challenged intranasally with the Ames strain and 48 hours post-challenge were treated via the IP route with either AVP-21D9 (195 \u00b5g\/mouse) or the molar equivalent of AVP-21D9-PlyG (216 ug\/mouse), or with vehicle control. Mice were monitored daily for morbidity and mortality for a period of 20 days post-challenge.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-14\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPost-challenge mouse efficacy studies for s.c. route of infection\u003C\/h3\u003E\u003Cp id=\u0022p-39\u0022\u003EThe post-challenge therapeutic efficacy of AVP-21D9-PlyG compared with parental AVP-21D9 antibody was determined in two independent experiments, with delay of treatment to 18-24 hr post-challenge. A higher IgG dose of 330 \u00b5g\/mouse and an equimolar ISTAb dose was used in these studies. The combined data of these two studies (n=24 for treatment group, and n=20 for control) are shown in \u003Ca id=\u0022xref-fig-5-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFig. 5F\u003C\/a\u003E. Statistical analysis (Log-rank) showed highly significant protection provided by AVP-21D9-PlyG compared to the untreated group (p\u0026lt;0.0001). Furthermore, the difference in protection provided by the ISTAb \u003Cem\u003Evs\u003C\/em\u003E. parental AVP-21D9 was also statistically significant (p=0.0101). Bacterial burden in the liver, lung, and spleen of surviving animals was consistently lower in ISTAb-treated animals compared to parental IgG (\u003Ca id=\u0022xref-fig-5-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFig. 5G\u003C\/a\u003E).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-15\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPre-challenge mouse efficacy studies for respiratory route of infection\u003C\/h3\u003E\u003Cp id=\u0022p-40\u0022\u003EPre-challenge efficacy of the AVP-21D9-PlyG against respiratory \u003Cem\u003EB. anthracis\u003C\/em\u003E challenge was compared with its parental IgG, AVP-21D9. Mice received intraperitoneal (i.p.) treatment with either buffer vehicle as control (n=19), or molar-equivalent IgG or ISTAb doses of 65 \u00b5g\/mouse and 72 \u00b5g\/mouse respectively (n=24 per group). At two hours post-treatment, the mice were challenged intranasally (i.n.) with 5LD\u003Csub\u003E50\u003C\/sub\u003E \u003Cem\u003EB. anthracis\u003C\/em\u003E Ames spores and monitored daily for morbidity and mortality for 20 days (\u003Ca id=\u0022xref-fig-5-8\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFig. 5H\u003C\/a\u003E). All surviving mice appeared completely healthy based on the scoring criteria, and statistical analysis (Log-rank) showed highly significant protection provided by AVP-21D9-PlyG (100% survival) compared to the untreated group (p\u0026lt;0.0001). Furthermore, the statistical difference in protection provided by the ISTAb vs. parental AVP-21D9 was also highly significant (p=0.0013).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-16\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPost-challenge mouse efficacy studies for respiratory route of infection\u003C\/h3\u003E\u003Cp id=\u0022p-41\u0022\u003EIn two fully independent experiments, AVP-21D9-PlyG was compared with parental IgG for therapeutic efficacy against the respiratory route of anthrax infection. Mice were challenged i.n. with 5LD\u003Csub\u003E50\u003C\/sub\u003E \u003Cem\u003EB. anthracis\u003C\/em\u003E Ames. Then, at 48 hr post-challenge, the mice received i.p. administration of either vehicle as control (n=10), or molar-equivalent IgG or ISTAb doses of 195 \u00b5g\/mouse and 216 \u00b5g\/mouse respectively (n=20 per group). The mice were monitored daily for morbidity and mortality for a period of 20 days post-challenge. Combined data for these two studies are shown in \u003Ca id=\u0022xref-fig-5-9\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFig. 5I\u003C\/a\u003E. All surviving mice at the end of both studies appeared completely healthy based on scoring criteria, and statistical analysis (Log-rank) showed highly significant protection provided by AVP-21D9-PlyG (100% survival) compared to the untreated group (p\u0026lt;0.0001). Furthermore, the difference in protection provided by the ISTAb vs. parental AVP-21D9 was also statistically significant (p=0.0182). These data, together with the post-challenge results for the s.c. route of infection, establish the proof-of-concept that conferring surface binding property to a neutralizing PA antibody significantly enhances its \u003Cem\u003Ein vivo\u003C\/em\u003E therapeutic efficacy.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-17\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPharmacokinetic analysis of B. anthracis ISTAbs in mice\u003C\/h3\u003E\u003Cp id=\u0022p-42\u0022\u003EAs a preliminary evaluation of the relative bioavailability of ISTAbs versus IgG, we treated a group of three mice with AVP-21D9, M18, W2, or molar equivalents of their respective PlyG ISTAbs. Samples were collected on days 3, 7, 14, 21, and 28. IgG levels (\u00b5g\/ml) were measured using a quantitative sandwich ELISA. As shown in \u003Ca id=\u0022xref-fig-6-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6A-C\u003C\/a\u003E, serum antibody concentrations were higher in the IgG groups on day 3 compared to ISTAbs. This is remarkable in that the ISTAbs showed superior efficacy despite apparent lower bioavailability compared to parental antibodies.\u003C\/p\u003E\u003Cdiv id=\u0022F6\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F6.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Pharmacokinetic studies in Mice. The pK measurement of CWT domain of ISTAb derivatives of AVP-21D9, W2, and M18 in comparison with respective IgGs as determined by ELISA, using plates coated with isolated PlyG domain. Samples were run in duplicates. (A-C) Preliminary pK analysis of ISTAb vs. IgG. Mice (n=3) were treated with 330 \u0026#xB5;g\/animal of either IgG or ISTAb on day 0. Serum samples were collected on days 3, 7, 14, 21, and 28 to compare the anti-PA binding titers. Mean values from three mice and associated errors are plotted\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1518606228\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Pharmacokinetic studies in Mice.\u0026lt;\/span\u0026gt; The pK measurement of CWT domain of ISTAb derivatives of AVP-21D9, W2, and M18 in comparison with respective IgGs as determined by ELISA, using plates coated with isolated PlyG domain. Samples were run in duplicates. \u0026lt;strong\u0026gt;(A-C)\u0026lt;\/strong\u0026gt; Preliminary pK analysis of ISTAb vs. IgG. Mice (n=3) were treated with 330 \u0026#xB5;g\/animal of either IgG or ISTAb on day 0. Serum samples were collected on days 3, 7, 14, 21, and 28 to compare the anti-PA binding titers. Mean values from three mice and associated errors are plotted\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Fig. 6:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F6.medium.gif\u0022 width=\u0022440\u0022 height=\u0022113\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Fig. 6:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F6.medium.gif\u0022 width=\u0022440\u0022 height=\u0022113\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F6.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Fig. 6:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F6.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFig. 6:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EPharmacokinetic studies in Mice.\u003C\/span\u003E\u003Cp id=\u0022p-43\u0022 class=\u0022first-child\u0022\u003EThe pK measurement of CWT domain of ISTAb derivatives of AVP-21D9, W2, and M18 in comparison with respective IgGs as determined by ELISA, using plates coated with isolated PlyG domain. Samples were run in duplicates. \u003Cstrong\u003E(A-C)\u003C\/strong\u003E Preliminary pK analysis of ISTAb vs. IgG. Mice (n=3) were treated with 330 \u00b5g\/animal of either IgG or ISTAb on day 0. Serum samples were collected on days 3, 7, 14, 21, and 28 to compare the anti-PA binding titers. Mean values from three mice and associated errors are plotted\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-18\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EISTAb evaluation in a rhesus macaques inhalational anthrax model\u003C\/h3\u003E\u003Cp id=\u0022p-44\u0022\u003EWe performed a therapeutic evaluation of ISTAb with separate cohorts (n=5, AVP-21D9; n=5, AVP-21D9-PlyG; n=4, sham-treated controls), with all groups receiving equivalent comparable therapeutic or sham doses (20 mg\/kg) by intravenous administration 24h post aerosol challenge. Initially, all animals were aerosol challenged with a target inhalation dose of 1.0E+08 of virulent \u003Cem\u003EB. anthracis\u003C\/em\u003E spores (Ames). Results of the aerosol challenge (\u003Ca id=\u0022xref-fig-7-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7A\u003C\/a\u003E) shows individual dosing was not significantly different between experimental groups, and the overall mean delivered dose (3.32E+08 \u00b1 1.73E+08) approximated the target challenge dose. All animals in AVP-21D9 and AVP-21D9-PlyG treatment groups survived lethal aerosol challenge, whereas sham-treated animals succumbed to disease 112-128h post challenge (\u003Ca id=\u0022xref-fig-7-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7B\u003C\/a\u003E). All four animals in sham-treatment control group demonstrated blood bacteremia (\u003Ca id=\u0022xref-fig-7-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7C\u003C\/a\u003E) indicative of hematogenous spread and fulminant anthrax disease, including prominent bacterial loading in bronchoalveolar lavage (BAL) samples taken at necropsy (\u003Ca id=\u0022xref-fig-7-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7D\u003C\/a\u003E). No animals in either AVP-21D9 or AVP-21D9-PlyG treatment groups experienced blood bacteremia and survived until termination of the experiment (day-21 PI). Residual bacterial loading in necropsy BAL samples in the AVP-21D9 and AVP-21D9-PlyG groups were observed (\u003Ca id=\u0022xref-fig-7-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7D\u003C\/a\u003E). Colony counts in the lung lavage of treated animals may have been the result of ungerminated spores sequestered in the lung at day 21 post challenge.\u003C\/p\u003E\u003Cdiv id=\u0022F7\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F7.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Nonhuman primate efficacy studies. Rhesus macaques (n=4) were exposed by aerosol to B. anthracis sp. Ames. (A) Determination of individual animal aerosol inhaled challenge dose (CFU\/animal), (B) Survival curve, (C) Blood bacteremia in control animals postexposure excluding one animal (MK12) where samples were impossible to obtain; there was no detectable bacteremia in any of the treated animals during any times postexposure, including necropsy, (D) Determination of bacterial concentrations from bronchoalveolar lavage samples taken at necropsy. (E) NHP pK study. NHPs (n=4) were infused with 20 mg\/kg of either AVP-21D9-PlyG or AVP-21D9-IgG and the concentration of antibodies in serum was measured at days D1, D2, D7, D10, D14, D42, and D70. Mean values of concentration of antibody from four NHPs and error bars for standard deviations were plotted.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1518606228\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Nonhuman primate efficacy studies.\u0026lt;\/span\u0026gt; Rhesus macaques (n=4) were exposed by aerosol to \u0026lt;em\u0026gt;B. anthracis\u0026lt;\/em\u0026gt; sp. Ames. \u0026lt;strong\u0026gt;(A)\u0026lt;\/strong\u0026gt; Determination of individual animal aerosol inhaled challenge dose (CFU\/animal), \u0026lt;strong\u0026gt;(B)\u0026lt;\/strong\u0026gt; Survival curve, \u0026lt;strong\u0026gt;(C)\u0026lt;\/strong\u0026gt; Blood bacteremia in control animals postexposure excluding one animal (MK12) where samples were impossible to obtain; there was no detectable bacteremia in any of the treated animals during any times postexposure, including necropsy, \u0026lt;strong\u0026gt;(D)\u0026lt;\/strong\u0026gt; Determination of bacterial concentrations from bronchoalveolar lavage samples taken at necropsy. \u0026lt;strong\u0026gt;(E)\u0026lt;\/strong\u0026gt; NHP pK study. NHPs (n=4) were infused with 20 mg\/kg of either AVP-21D9-PlyG or AVP-21D9-IgG and the concentration of antibodies in serum was measured at days D1, D2, D7, D10, D14, D42, and D70. Mean values of concentration of antibody from four NHPs and error bars for standard deviations were plotted.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Fig. 7:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F7.medium.gif\u0022 width=\u0022440\u0022 height=\u0022221\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Fig. 7:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F7.medium.gif\u0022 width=\u0022440\u0022 height=\u0022221\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F7.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Fig. 7:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2024\/09\/25\/2024.09.23.24313920\/F7.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFig. 7:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003ENonhuman primate efficacy studies.\u003C\/span\u003E\u003Cp id=\u0022p-45\u0022 class=\u0022first-child\u0022\u003ERhesus macaques (n=4) were exposed by aerosol to \u003Cem\u003EB. anthracis\u003C\/em\u003E sp. Ames. \u003Cstrong\u003E(A)\u003C\/strong\u003E Determination of individual animal aerosol inhaled challenge dose (CFU\/animal), \u003Cstrong\u003E(B)\u003C\/strong\u003E Survival curve, \u003Cstrong\u003E(C)\u003C\/strong\u003E Blood bacteremia in control animals postexposure excluding one animal (MK12) where samples were impossible to obtain; there was no detectable bacteremia in any of the treated animals during any times postexposure, including necropsy, \u003Cstrong\u003E(D)\u003C\/strong\u003E Determination of bacterial concentrations from bronchoalveolar lavage samples taken at necropsy. \u003Cstrong\u003E(E)\u003C\/strong\u003E NHP pK study. NHPs (n=4) were infused with 20 mg\/kg of either AVP-21D9-PlyG or AVP-21D9-IgG and the concentration of antibodies in serum was measured at days D1, D2, D7, D10, D14, D42, and D70. Mean values of concentration of antibody from four NHPs and error bars for standard deviations were plotted.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-19\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPharmacokinetic studies in NHPs\u003C\/h3\u003E\u003Cp id=\u0022p-46\u0022\u003ESerum samples from two male and two female rhesus macaques treated by IV infusion with a single dose (20 mg\/kg) of AVP-21D9 or AVP-21D9-PlyG were collected after days 0, 1, 2, 4, 7, 10, 14, 42, 70, and 99. As shown in Supplemental Table S4, t1\/2(d) and C\u003Csub\u003Emax\u003C\/sub\u003E (\u03bcg\/ml) values of AVP-21D9-PlyG were 4.21 (days) and 73.88 (\u03bcg\/mL) respectively, which were two folds and three folds lower than the t1\/2(d) and C\u003Csub\u003Emax\u003C\/sub\u003E (\u03bcg\/ml) of parental IgG, respectively. The serum concentration plot (\u003Ca id=\u0022xref-fig-7-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7E\u003C\/a\u003E) exhibited a significantly lower bioavailability of the PlyG ISTAb when compared with parental IgG (multiple t-test, p=\u0026lt;0.001). These data further demonstrate the efficacy of ISTAbs despite suboptimal PK properties.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-20\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EImmunogenicity studies\u003C\/h3\u003E\u003Cp id=\u0022p-47\u0022\u003ENHP PK serum samples from days 42, 70, and 99 were analyzed for anti-PlyG antibodies, especially in group 1 NHP, which were treated with 20 mg\/kg of AVP-21D9-PlyG. As shown in Fig. S4, there were no significant anti-PlyG titers detected in group 1 NHP treated with AVP-21D9-PlyG (ED\u003Csub\u003E50\u003C\/sub\u003E \u0026lt;1.0).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-21\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EApplication of ISTAb technology to C. difficile\u003C\/h3\u003E\u003Cp id=\u0022p-48\u0022\u003EAs a proof of concept for broad applicability of the technology, we also generated and characterized several ISTAb for \u003Cem\u003EC. difficile\u003C\/em\u003E as another Gram-positive pathogen. We bioinformatically screened all sequenced \u003Cem\u003EC. difficile\u003C\/em\u003E bacteriophages as well as all sequenced \u003Cem\u003EC. difficile\u003C\/em\u003E bacterial genomes, which contain prophage sequences, for potential phage endolysins. Twenty-five endolysin or endolysin-like sequences were analyzed using the PFAM database to identify catalytic domains and define domain boundaries. Endolysins that lacked known CWT domains or had less than 50 non-catalytic domain amino acids, were excluded from further analysis. The remaining CWTs were aligned and compared for percent sequence identity. Duplicate sequences were eliminated and those with \u0026gt;95% identity was condensed into one archetype sequence. Eventually, six \u003Cem\u003EC. difficile\u003C\/em\u003E endolysin CWT families (630A, QCD, CD27L, C2, CD119, and CCL2), which ranged from 30% to 90% identity, were selected for further study (Fig. S5A). All six \u003Cem\u003EC. difficile\u003C\/em\u003E CWTs were chemically synthesized, expressed, and qualitatively screened for binding by fluorescent microscopy against 11 \u003Cem\u003EC. difficile\u003C\/em\u003E strains and 12 additional anaerobic strains that included those known to colonize the gastrointestinal tract (i.e., other members of the Clostridiaceae, Lactobacillaceae, and Bacteroidaceae families). Ultimately, the 630A and CCL2 CWTs were selected for generation of \u003Cem\u003EC. difficile\u003C\/em\u003E ISTAbs because they displayed: 1) high yield and ease of purification (Fig. S5B); 2) the ability to bind all \u003Cem\u003EC. difficile\u003C\/em\u003E strains with negligible or no binding to non-\u003Cem\u003EC. difficile\u003C\/em\u003E strains (Fig. S5C); and 3) the lowest homology between all six CWTs (30% identity, Fig. S5A). A representative image showing binding of AlexaFlour-labeled 630A to \u003Cem\u003EC. difficile\u003C\/em\u003E strain BAA1812 is shown in Fig. S5D).\u003C\/p\u003E\u003Cp id=\u0022p-49\u0022\u003EFor ISTAbs generation for \u003Cem\u003EC. difficile\u003C\/em\u003E, we selected the well characterized humanized monoclonal anti-TcdA (6G5) and anti-TcdB (9H10), and the 630A (accession no. YP_001088405.1) and CCL2 (accession no. CCL24417.1) as CWTs. We characterized both IgGs and ISTAbs using SDS-PAGE (Fig. S5E), size exclusion HPLC (Fig. S5F), and binding and neutralizing activity assays. The binding curves for parental antibodies and ISTAbs were essentially indistinguishable (Fig. S5G). Using a Caspase-based cytotoxicity assay (\u003Cem\u003E\u003Ca id=\u0022xref-ref-35-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-35\u0022\u003E35\u003C\/a\u003E\u003C\/em\u003E) for TcdA and TcdB (Fig. S5H) we showed that both IgGs and ISTAb exhibit comparable neutralizing potency (Fig. S5I-K). All four ISTAb constructs possessed binding specificity for \u003Cem\u003EC. difficile\u003C\/em\u003E with little to no binding observed for non-\u003Cem\u003EC. difficile\u003C\/em\u003E strains or species (Fig. S5C). Furthermore, all 630A ISTAbs consistently showed strong binding to Fc\u03b3R1A, R2A, R3A and low binding to the inhibitory Fc\u03b3R2B for both TcdA (Fig. S6A) and TcdB (Fig. S6B). In no instance was the binding to the respective receptor lower for ISTAbs compared to parental antibodies.\u003C\/p\u003E\u003Cp id=\u0022p-50\u0022\u003EWe also analyzed sero-reactivity of 47 human serum samples to the \u003Cem\u003EC. difficile\u003C\/em\u003E CCL2 and 630A CWTs. As controls, we used the \u003Cem\u003ES. aureus\u003C\/em\u003E toxic shock syndrome toxin 1 (TSST-1), for which we expect seroprevalence, and purified glycoprotein (GP) of Ebola virus as negative control. As shown in Fig. S6C, while we observed strong reactivity of the sera to TSST-1 and a few serum samples unexpectedly showed some reactivity to Ebola GP, the lowest reactivity was observed for 630A and CCL2 (significantly lower than TSST-1, p\u0026lt;0.0001). The reactivity of 630A, but not CCL2, was significantly lower than Ebola GP (P=0.0202). Stability studies also showed that the IgG and ISTAbs remained remarkably stable over the study period (Fig. S7A-C).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-22\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EC. difficile ISTAb in vivo efficacy study in Hamsters\u003C\/h3\u003E\u003Cp id=\u0022p-51\u0022\u003EPrior to spore challenge, Golden Syrian hamsters were treated on days -1, 0, +1, and +2 relative to infection (similar to regimen reported previously for bezlotoxumab) with either parental IgG or molar equivalent of a cocktail of TcdA and TcdB ISTAbs (1 mg\/hamster per day). On Day -1, animals received a single dose of 10 mg\/kg clindamycin by intraperitoneal injection (IP) to wipe out the intestinal flora. On day 0, animals received an intragastric dose of 100 spores of \u003Cem\u003EC. difficile\u003C\/em\u003E clinical isolate 630 (ATCC\u003Csup\u003E\u00ae\u003C\/sup\u003E BAA-1382\u2122). While there were no survivors in the group treated with control IgG, the cocktail treatment group showed 60% survival (Fig. S6D) and the weight loss started to level off about 4-5 days post infection (Fig. S6E).\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-23\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EDiscussion\u003C\/h2\u003E\u003Cp id=\u0022p-52\u0022\u003EEngineered antibodies that embody multiple functions into a single molecule are highly desirable therapeutics. Recent advances in antibody engineering allow for the generation of antibodies consisting of two different heavy\/light chain combinations, or multiple antigen binding domains, each possessing distinct binding specificities. These \u201cbispecific\u201d mAbs can simultaneously bind two different antigens or epitopes of the same antigen to increase affinity or enable bifunctionality. As an example, a bispecific mAb (BiS4Pa) was created that targets Psl, the \u003Cem\u003EPseudomonas aeruginosa\u003C\/em\u003E exopolysaccharide, and PcrV, a type III secretion system protein, and demonstrated superior protection in a \u003Cem\u003EP. aeruginosa\u003C\/em\u003E\u2013induced murine pneumonia model compared to parental mAb combinations (\u003Cem\u003E\u003Ca id=\u0022xref-ref-36-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-36\u0022\u003E36\u003C\/a\u003E\u003C\/em\u003E). In another study, an antibody-antibiotic conjugate was used to kill intracellular \u003Cem\u003ES. aureus\u003C\/em\u003E (\u003Cem\u003E\u003Ca id=\u0022xref-ref-37-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-37\u0022\u003E37\u003C\/a\u003E\u003C\/em\u003E). In this approach, an IgG bound the conserved \u003Cem\u003ES. aureus\u003C\/em\u003E wall teichoic acid and upon Fc-mediated OPK phagolysosomal proteases cleaved a labile bond releasing rifampicin conjugated to the mAb. This antibody-antibiotic conjugate was shown to be superior to vancomycin \u003Cem\u003Ein vitro\u003C\/em\u003E and \u003Cem\u003Ein vivo.\u003C\/em\u003E Our current study expands the concept of bifunctional antibodies to integration of toxin neutralization and Fc-mediated effector functions into a single molecule in form of ISTAbs.\u003C\/p\u003E\u003Cp id=\u0022p-53\u0022\u003EISTAbs have several favorable features as shown in \u003Ca id=\u0022xref-fig-1-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig.1B\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-1-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EC\u003C\/a\u003E: \u003Cem\u003Ei)\u003C\/em\u003E They show specific and high-affinity binding to the infectious agent, mediated by the CWT (\u003Cem\u003E\u003Ca id=\u0022xref-ref-38-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-38\u0022\u003E38\u003C\/a\u003E\u003C\/em\u003E); \u003Cem\u003Eii)\u003C\/em\u003E They are expected to enhance binding by the avidity effect since each ISTAb carries two CWT domains; \u003Cem\u003Eiii)\u003C\/em\u003E They are expected to accumulate on the bacterial surface at the site of infection where the anti-toxin is needed; \u003Cem\u003Eiv)\u003C\/em\u003E They are expected to sequester toxin to prevent release in the tissues and circulation; and, \u003Cem\u003Ev)\u003C\/em\u003E ISTAbs provide opsonic activity to enhance clearance of the bacteria and targeted toxin by the phagocytes that engulf the bacteria.\u003C\/p\u003E\u003Cp id=\u0022p-54\u0022\u003EAs proof of concept, we have tested ISTAb efficacy against both \u003Cem\u003EB. anthracis\u003C\/em\u003E and \u003Cem\u003EC. difficile\u003C\/em\u003E infections. Currently, there is no approved vaccine for C. difficile, and the only approved \u003Cem\u003EB. anthracis\u003C\/em\u003E vaccine is plagued with reactogenicity and other side effects. Notably, challenges to vaccination strategies that stem from the inability to generate a long-lasting and protective response continue to exist, as manifested by very recent clinical trial failures of both Sanofi and Pfizer \u003Cem\u003EC. difficile\u003C\/em\u003E vaccines (\u003Cem\u003E\u003Ca id=\u0022xref-ref-39-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-39\u0022\u003E39\u003C\/a\u003E\u003C\/em\u003E). Immunotherapeutics as agents that can be used post-expodure and provide immediate protection both in general population and immunosuppressed patients remain an important tool for management of bacterial infections.\u003C\/p\u003E\u003Cp id=\u0022p-55\u0022\u003EPA has been a key target for anthrax immunotherapies (\u003Cem\u003E\u003Ca id=\u0022xref-ref-4-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-4\u0022\u003E4\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-6-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E\u003C\/em\u003E). A fully human mAb, called raxibacumab, is the first biological product to be approved through the FDA Animal Rule (\u003Cem\u003E\u003Ca id=\u0022xref-ref-40-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-40\u0022\u003E40\u003C\/a\u003E\u003C\/em\u003E), and shown to be effective in New Zealand white rabbits and cynomolgus macaques. Raxibacumab was found to be safe at 40 mg\/kg in clinical studies with more than 300 healthy adults, including 43 individuals receiving a double dose (\u003Cem\u003E\u003Ca id=\u0022xref-ref-41-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-41\u0022\u003E41\u003C\/a\u003E\u003C\/em\u003E). Another human mAb, called MDX-1303 (Valortim), was shown to be effective in prophylactic and post-symptomatic treatment of rabbits exposed to aerosolized \u003Cem\u003EB. anthracis\u003C\/em\u003E spores, and a single intramuscular injection of 1 mg\/kg of body weight fully protected monkeys challenged with aerosolized \u003Cem\u003EB. anthracis\u003C\/em\u003E spores (\u003Cem\u003E\u003Ca id=\u0022xref-ref-42-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-42\u0022\u003E42\u003C\/a\u003E\u003C\/em\u003E). Based on the published data, the IC\u003Csub\u003E50\u003C\/sub\u003E of raxibacumab is 0.21 nM (\u003Cem\u003E\u003Ca id=\u0022xref-ref-43-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-43\u0022\u003E43\u003C\/a\u003E\u003C\/em\u003E), which is very close to the lead IgG molecule AVP-21D9 (IC\u003Csub\u003E50\u003C\/sub\u003E = 0.3 nM) used in our study, and we have shown that the AVP-21D9-PlyG ISTAb has significantly better protection than AVP-21D9 in post-exposure studies of anthrax challenge using a mouse model. Therefore, we expect that AVP-21D9-PlyG will have superior protection compared to raxibacumab. The key advantage of our approach over raxibacumab is that ISTAbs display the same anti-toxin properties while at the same time they bind to the surface of the bacteria to trigger an innate immune response to clear the infection. This rapid clearance of bacteria is expected to significantly enhance the efficacy of the ISTAbs beyond what has been achieved with raxibacumab. In support of superior ISTAb effects, results similar to \u003Cem\u003EB. anthracis\u003C\/em\u003E studies were obtained with our \u003Cem\u003Ein vitro\u003C\/em\u003E and \u003Cem\u003Ein vivo\u003C\/em\u003E analysis of ISTAb efficacy against \u003Cem\u003EC. difficile\u003C\/em\u003E. In addition to inducing bacterial clearance by triggering OPK and toxin neutralization, ISTAbs create a concentration gradient towards the site of infection, where these therapeutic molecules are needed the most. A similar class of therapeutic molecules, called lysibodies, contain an IgG Fc fused with an endolysin CWT domain targeting \u003Cem\u003ES. aureus\u003C\/em\u003E (\u003Cem\u003E\u003Ca id=\u0022xref-ref-44-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-44\u0022\u003E44\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-45-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-45\u0022\u003E45\u003C\/a\u003E\u003C\/em\u003E). Lysibodies were shown to promote phagocytosis by macrophages and neutrophils, and to protect mice from methicillin-resistant \u003Cem\u003ES. aureus\u003C\/em\u003E (MRSA) infection in two model systems (\u003Cem\u003E\u003Ca id=\u0022xref-ref-44-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-44\u0022\u003E44\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-45-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-45\u0022\u003E45\u003C\/a\u003E\u003C\/em\u003E). Unlike ISTAbs, lysibodies do not possess the Fab fragment of IgG (\u003Cem\u003E\u003Ca id=\u0022xref-ref-44-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-44\u0022\u003E44\u003C\/a\u003E\u003C\/em\u003E), so they are devoid of antigen specific binding and\/or neutralization. In this respect, ISTAbs represent a superior therapeutic by combining surface binding with toxin neutralization, particularly for pathogens that utilize secreted virulence factors such as toxins.\u003C\/p\u003E\u003Cp id=\u0022p-56\u0022\u003EAlthough the core IgG of the AVP-21D9-PlyG ISTAb is of human origin, it could be a potential drawback if the PlyG CWT domain leads to immunogenicity, as anti-CWT antibodies could neutralize these therapeutic molecules. However, treatment with an ISTAb would likely be used only a few times in a patient\u2019s lifetime when a life-threating infection occurs, so the immunogenic potential of CWT would be a minor concern. Moreover, our studies clearly addressed this issue showing that the CWT domains, specifically PlyG, is not immunogenic in a mouse model when ISTAb administration mimicked the expected clinical treatment dose and route (\u003Ca id=\u0022xref-fig-4-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig.4C\u003C\/a\u003E). Additionally, naturally occurring antibodies against the PlyG and PlyL CWTs were not detected when plasma from 88 individuals were analyzed (\u003Ca id=\u0022xref-fig-4-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4D\u003C\/a\u003E) for preexisting antibodies titers. Consistent with these findings, we obtained the same results for the CWT domains of the ISTAbs used in the \u003Cem\u003EC. difficile\u003C\/em\u003E studies. Moreover, there is evidence from multiple endolysins suggesting that even if antibodies are produced against these proteins, they are non-neutralizing, presumably due to the high-affinity of the CWTs for the bacterial surface (\u003Cem\u003E\u003Ca id=\u0022xref-ref-46-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-46\u0022\u003E46\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-47-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-47\u0022\u003E47\u003C\/a\u003E\u003C\/em\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-57\u0022\u003EThe observed efficacy of ISTAbs is remarkable in light of our data showing that they have lower bioavailability. This suggests that further engineering of these molecules to improve PK properties can further increase efficacy of ISTAbs. Thus, future direction involves introduction of mutations in the Fc domain of ISTAbs such as YTE and LS mutations that increase IgG\u2019s affinity for neonatal Fc receptor at acidic pH and promote recycling of IgG back into circulation.\u003C\/p\u003E\u003Cp id=\u0022p-58\u0022\u003EIn summary, we tested and evaluated the ISTAbs as a new therapeutic platform technology, which could target any secreted virulence factor (toxins, enzymes, and other immunomodulating proteins) on the bacterial surface at the site of infection. Using anti-toxin ISTAbs, we have shown that ISTAbs maintain whole cell binding as well as toxin neutralizing functions. ISTAbs also trigger OPK in contrast to the parental IgGs. Most importantly, the anti-PA AVP-21D9-PlyG ISTAb confers significantly better protection when efficacy is compared with equimolar IgG alone in a post-challenge anthrax mouse model. These observations provide proof of principle for wide ranging applications of this technology against toxigenic bacteria.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-24\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EMethods\u003C\/h2\u003E\u003Cdiv id=\u0022sec-25\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EIdentification of CWTs for ISTAb construction\u003C\/h3\u003E\u003Cp id=\u0022p-59\u0022\u003EPhylogenetic trees based on seed alignments of all accumulated \u003Cem\u003EB. anthracis\u003C\/em\u003E endolysins were assembled by FastTree on 100 resamples. Five unique \u003Cem\u003EB. anthracis\u003C\/em\u003E endolysins were ultimately selected for gene synthesis. These include the CWT domains from PlyG (ABB55421.1), the endolysin of the \u03b3 phage, PlyB (YP_009031336), the endolysin from the Bcp1 phage, PlyL (NP_846312.1), the endolysin from the lambda B02 prophage lysogenized in the \u003Cem\u003EB. anthracis\u003C\/em\u003E Ames strain, PlyAP50 (YP_002302543.1), the putative endolysin from the AP50 phage, and PlyTsamsa (YP_008873459.1), the endolysin from phage Tsamsa. \u003Cem\u003EC. difficile\u003C\/em\u003E specific CWT identification method has been described in Supplemental Method 1.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-26\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EExpression and purification of CWTs\u003C\/h3\u003E\u003Cp id=\u0022p-60\u0022\u003EFive endolysin CWT domains from \u003Cem\u003EB. anthracis\u003C\/em\u003E-specific phages and six from \u003Cem\u003EC. difficile\u003C\/em\u003E were codon-optimized for expression in \u003Cem\u003EE. coli\u003C\/em\u003E, synthesized (GeneArt), and subcloned into an arabinose-inducible pBAD24 expression vector, sequenced (Macrogen) to confirm identity, and eventually transformed into BL21 (DE3) competent \u003Cem\u003EE. coli.\u003C\/em\u003E Proteins were expressed in \u003Cem\u003EE. coli\u003C\/em\u003E and cell lysates were used to extract and purify CWTs. An example figure for the PlyL and PlyG CWTs based on pBAD24 expression is shown in Fig. S8.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-27\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EBacterial binding specificity of CWTs\u003C\/h3\u003E\u003Cp id=\u0022p-61\u0022\u003EThe PlyL and PlyG CWTs (\u003Cem\u003EB. anthracis\u003C\/em\u003E), and CCL2 and 630A (\u003Cem\u003EC. difficile\u003C\/em\u003E), were chemically crosslinked to AlexaFluor\u003Csup\u003E\u00ae\u003C\/sup\u003E-555 according to manufacturer\u2019s instructions (ThermoFisher Scientific). Briefly, 0.5 ml of CWTs (2.0 mg\/ml) was mixed with 50 \u00b5l of 1 M sodium bicarbonate and reacted with 20 \u00b5l of AlexaFluor\u003Csup\u003E\u00ae\u003C\/sup\u003E-555 dye (2 mg\/ml in DMSO). The reaction mixture was incubated at RT for 1 hr and unreacted dye was removed by application to a PD-10 desalting column (GE Healthcare).\u003C\/p\u003E\u003Cp id=\u0022p-62\u0022\u003E\u003Cem\u003EBacillus\u003C\/em\u003E strains (\u003Ca id=\u0022xref-fig-2-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2B\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-2-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003E2C\u003C\/a\u003E) and \u003Cem\u003EC. difficile\u003C\/em\u003E strains (Fig. S5C) were obtained from the American Type Culture Collection (ATCC), or BEI Resources, and grown in Brain-Heart Infusion (BHI) medium overnight (o\/n). The next morning, cells were washed 2X in PBS and 20 \u00b5g of labelled CWT was added to 100 \u00b5l of bacterial cells and allowed to incubate at RT for 10 min. The reaction in the absence of fluorescent dye served as a control for autofluorescence. After incubation, labeled bacterial cells were pelleted and washed with PBS, diluted to 100 \u00b5l again, and 1 \u00b5l of this mixture was applied to a microscope glass slide and sealed with glass coverslip. Bacteria were viewed via both bright field microscopy and fluorescent microscopy by a Nikon Eclipse 80i microscope for all BSL-2 strains or a Nikon Eclipse Ts2 microscope for the BSL-3 strains (\u003Cem\u003EB. anthracis\u003C\/em\u003E Ames and ASC506). The NIS-Elements software was utilized for image analysis.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-28\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ESeroprevalence of CWT domains in healthy humans\u003C\/h3\u003E\u003Cp id=\u0022p-63\u0022\u003EHuman serum samples from healthy donors (Emergent BioSolutions plasmapheresis program) (\u003Cem\u003E\u003Ca id=\u0022xref-ref-34-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-34\u0022\u003E34\u003C\/a\u003E\u003C\/em\u003E) were assessed for pre-existing antibody titers against the CWTs from PlyL or PlyG, or Hla as a positive control (for \u003Cem\u003EB. anthracis)\u003C\/em\u003E and CCL2 and 630A (for \u003Cem\u003EC. difficile\u003C\/em\u003E). Proteins (100 ng\/well) were coated in NUNC ELISA plates o\/n at 4\u00b0C. Plates were blocked for 1 h at RT. Serum samples were diluted at 1:200 in PBS and detected using anti-human IgG-HRP. The OD\u003Csub\u003E650nm\u003C\/sub\u003E values were recorded and EC\u003Csub\u003E50\u003C\/sub\u003E values were analyzed as described previously.\u003C\/p\u003E\u003Cp id=\u0022p-64\u0022\u003E\u003Cem\u003EC. difficile\u003C\/em\u003E specific method has been described in Supplemental Method 2.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-29\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ESelection and construction of IgGs and ISTAbs\u003C\/h3\u003E\u003Cp id=\u0022p-65\u0022\u003ESequences of three mAbs M18 (accession number 3ETB_F), W2 (ABB02452), and AVP-21D9 (ACK09999), were used to generate variable regions of heavy and light chains in human IgG scaffold. These sequences were cloned into pSF antibody expression vector. CWT domains were cloned with the native linker of the phage endolysin proteins (i.e., sequence linking the catalytic domain with the CWT domain); hence, no external linkers were utilized. All CWT sequences were codon optimized for human cell expression and included amino acids 164-233 of the PlyG endolysin (ABB55421.1), amino acids 191-284 of the PlyB endolysin (YP_009031336), and amino acids 165-234 of the PlyL endolysin (NP_846312.1).\u003C\/p\u003E\u003Cp id=\u0022p-66\u0022\u003E\u003Cem\u003EC. difficile\u003C\/em\u003E specific method has been described in Supplemental Method 3.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-30\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPurification and characterization of IgGs and ISTAbs\u003C\/h3\u003E\u003Cp id=\u0022p-67\u0022\u003EThe ExpiCHO system was used for the production of IgGs and ISTAbs as described previously(\u003Cem\u003E\u003Ca id=\u0022xref-ref-48-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-48\u0022\u003E48\u003C\/a\u003E\u003C\/em\u003E). Briefly, one mg of plasmid was transfected into ExpiCHO cells seeded at 6 x10\u003Csup\u003E6\u003C\/sup\u003E cells\/ml in a 1 L culture medium. Cells were harvested on day 14 and dialyzed against citrate buffer (20 mM citrate + 10 mM glycine + 8% sucrose pH 5.5) after purification.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-31\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EDifferential Scanning Fluorimetry\u003C\/h3\u003E\u003Cp id=\u0022p-68\u0022\u003EThermal stability of the parental IgGs and ISTAbs in 1% citrate buffer was assessed using differential scanning fluorimetry (DSF), as described previously (\u003Cem\u003E\u003Ca id=\u0022xref-ref-49-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-49\u0022\u003E49\u003C\/a\u003E\u003C\/em\u003E). In summary, SYPRO\u00ae Orange dye (Invitrogen, Carlsbad, USA) diluted in sterile dH\u003Csub\u003E2\u003C\/sub\u003E0 was added to the proteins to reach a final concentration of 6X within a reaction volume of 25 \u03bcl in a 96-well hard-shell plate with clear bottom (Bio-Rad). The thermal assay was performed in a Bio-Rad CFX Connect thermocycler wherein fluorescence measurements were made by increasing the temperature from 30 to 99\u00b0C at intervals of 0.1\u00b0C\/6s. The average melting temperature (T\u003Csub\u003Em\u003C\/sub\u003E) calculated from triplicates was defined as the vertex of the first derivative (dF\/dT) of relative fluorescence unit (RFU) values. Bovine serum albumin (Pierce) in 1X Dulbecco\u2019s phosphate-buffered saline (DPBS) pH 7.4 with a T\u003Csub\u003Em\u003C\/sub\u003E of 66 \u00b10.0\u00b0C was used as a control.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-32\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EELISA for IgG\/ISTAb binding to toxin\/bacteria\u003C\/h3\u003E\u003Cdiv id=\u0022sec-33\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EPA\/B. anthracis\u003C\/h4\u003E\u003Cp id=\u0022p-69\u0022\u003EStandard ELISAs were performed using previously published methods (\u003Cem\u003E\u003Ca id=\u0022xref-ref-50-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-50\u0022\u003E50\u003C\/a\u003E\u003C\/em\u003E). Protective antigen (BEI, Manassas, VA) was coated o\/n at 4\u00b0C in ELISA plates at 100 ng\/well. Next day, starting at 5 \u03bcg\/mL, two folds diluted IgGs and ISTAbs were added after blocking and detected by anti-human IgG-HRP. For whole cell binding assays, NUNC ELISA plates were coated with 100 \u03bcL of 0.4% formalin (vol\/vol) treated \u003Cem\u003EB. anthracis\u003C\/em\u003E UM23 o\/n at 4\u00b0C. The following day, two-folds diluted ISTAbs and IgGs were used as primary antibodies and detected with goat anti-human IgG-HRP antibody, and OD\u003Csub\u003E650nm\u003C\/sub\u003E values were recorded and EC\u003Csub\u003E50\u003C\/sub\u003E values determined. \u003Cem\u003EC. difficile\u003C\/em\u003E specific method has been described in Supplemental Method 4.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-34\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EOctet binding studies\u003C\/h3\u003E\u003Cp id=\u0022p-70\u0022\u003EBiolayer interferometry (BLI) kinetic assays were performed on an Octet Red96 System (Fortebio). For kinetic analysis of PA, ligands W2, W2-PlyG, AVP-21D9, or AVP-21D9-PlyG were diluted to 2 \u00b5g\/ml in 1X kinetics buffer and loaded onto pre-hydrated Protein G sensors (Fortebio) for 120 sec. After loading, a 60 sec baseline was used to establish stable ligand binding before dipping the coated sensors into a serial dilution of PA analyte. Analyte association was maintained for 300 seconds, followed by a 300 second dissociation step. To control for non-specific binding of PA to sensors in the absence of ligand, reference sensors were used in parallel for each concentration of PA and subtracted from total response. For AVP-21D9 and AVP-21D9-PlyG binding kinetics to Fc receptors, recombinant His-tagged Fc\u03b3R1A, Fc\u03b3R2A, Fc\u03b3R2B, or FcRn were loaded onto pre-hydrated Ni-NTA sensors for 120 sec before establishing a steady baseline in 1X kinetics buffer. Coated sensors were then transferred into a concentration range of analyte (AVP-21D9 or AVP-21D9-PlyG) for 300 sec, followed by a 300 sec dissociation step. Experiments were repeated in the absence of Fc receptors to control for non-specific binding. All data analyses were performed with ForteBio Data Analysis 9 software. To obtain \u003Cem\u003EK\u003C\/em\u003E\u003Csub\u003Eon\u003C\/sub\u003E, \u003Cem\u003EK\u003C\/em\u003E\u003Csub\u003Eoff\u003C\/sub\u003E, and \u003Cem\u003EK\u003C\/em\u003E\u003Csub\u003ED\u003C\/sub\u003E values, specific binding curves were fit globally to a 1:1 Langmuir binding model.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-35\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EToxicity and toxin neutralization assays\u003C\/h3\u003E\u003Cp id=\u0022p-71\u0022\u003EOur method was adopted and modified from Nungdi et al. (\u003Cem\u003E\u003Ca id=\u0022xref-ref-51-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-51\u0022\u003E51\u003C\/a\u003E\u003C\/em\u003E); \u003Cem\u003EToxicity assay\u003C\/em\u003E: RAW 264.7 cells were allowed to adhere to the plate surface at 37\u00b0C, 5% CO\u003Csub\u003E2,\u003C\/sub\u003E 95% humidity for 16-18 hr. Two-fold dilutions of PA and LF were prepared starting at 5 \u00b5g\/ml and added to cells at a 1:1 ratio and incubated at 37\u00b0C, 5% CO\u003Csub\u003E2,\u003C\/sub\u003E 95% humidity for 3 hours. After incubation, 50 \u03bcl of the reconstituted CellTiter-Glo (CTG) reagent was added and luminescence (emission at 560 nm) was measured. Toxicity was calculated as % toxicity = [1 \u2013 (% viable cells treated with PA and LF)\/ (% viable cells without treatment)] x 100. \u003Cem\u003EToxin neutralization assay (TNA)\u003C\/em\u003E: RAW 264.7 cells were prepared and seeded as described above. Two-fold or semi-log PA and LF dilutions were prepared in 96-well format in the same media, with concentrations starting at 1.25 \u00b5g\/ml and 0.16 \u00b5g\/ml, respectively. ISTAbs were diluted to 20 \u00b5g\/ml. PA and LF were mixed at a 1:1 ratio, and ISTAbs were added at a 1:1 ratio to the PA\/LF mix. PA\/LF\/ISTAb mix was incubated at RT for 30 min. As above, luminescence (emission at 560 nm) was measured after incubation. Toxin neutralization was calculated as % neutralization = (% viable cells treated with IgG or ISTAb and toxin)\/ (% viable cells without treatment) x 100.\u003C\/p\u003E\u003Cp id=\u0022p-72\u0022\u003E\u003Cem\u003EC. difficile\u003C\/em\u003E specific method has been described in Supplemental Method 5.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-36\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EISTAb\/IgG OPK activities\u003C\/h3\u003E\u003Cp id=\u0022p-73\u0022\u003EOPK assays were adopted and optimized based on previously described methods (\u003Cem\u003E\u003Ca id=\u0022xref-ref-52-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-52\u0022\u003E52\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-54-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-54\u0022\u003E54\u003C\/a\u003E\u003C\/em\u003E). Briefly, HL-60 cells were differentiated into neutrophil-like PMNs by growing in RPMI media containing 1.5% dimethyl sulfoxide (DMSO) and 10% FBS for 7-8 days (differentiation confirmed by expression of CD11b). For the OPK assays, three different final concentrations of 100, 50, and 25 \u00b5g\/ml of ISTAb or IgGs were made in Opsonization Buffer B (OBB; Hanks\u2019 balanced salt solution (HBSS) supplemented with CaCl\u003Csub\u003E2\u003C\/sub\u003E, MgCl\u003Csub\u003E2\u003C\/sub\u003E, 0.5% FBS, and 0.1% gelatin) and added to a sterile 96-well NUNC assay plate (20 \u03bcl\/well). Stock was diluted to \u223c10\u003Csup\u003E5\u003C\/sup\u003E CFU\/ml and 10 \u03bcl\/well of this diluted stock was added to the reaction mix. The plate was incubated for 30 minutes in a mini orbital shaker (700 rpm) at RT. Twenty-five microliter of PMN adjusted to 1\u00d710\u003Csup\u003E7\u003C\/sup\u003E cells\/ml in OBB and 25 \u00b5l of 1:8 diluted complement (Baby Rabbit -Pel-Freez Biologicals, LLC) were added to each well (total reaction mix: 80 \u00b5l\/well). OPK reactions were carried out by incubating for 45 minutes at 37\u00b0C, 1% CO\u003Csub\u003E2\u003C\/sub\u003E. A 10 \u00b5l volume of sample was plated on TSB agar plate and bacterial colonies on the agar plates were enumerated. The percent OPK was calculated using the following formula: % OPK = Average CFU count for bacteria without antibody (control) - Average CFU in samples with antibodies (test)\/Average CFU count for bacteria without antibody (control) X 100%.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-37\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EMouse ISTAb efficacy studies\u003C\/h3\u003E\u003Cdiv id=\u0022sec-38\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EI. Sub-protective dose optimization\u003C\/h4\u003E\u003Cp id=\u0022p-74\u0022\u003ESwiss-Webster mice at 8 weeks of age were injected via s.c route with the antibodies 2 hr before challenge with a lethal dose of the Ames strain of \u003Cem\u003EB. anthracis\u003C\/em\u003E spores (10LD\u003Csub\u003E50\u003C\/sub\u003E). The mice were monitored daily for morbidity and mortality for a period of 14 days post treatment, with daily health score assessments recorded according to our IACUC-approved Animal Health Score Chart.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-39\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EII. Pre-challenge efficacy studies for the s.c. route of infection\u003C\/h4\u003E\u003Cp id=\u0022p-75\u0022\u003EEfficacies of selected ISTAbs (AVP-21D9-PlyG and W2-PlyG) against anthrax challenge were compared with their parental antibodies (AVP-21D9 and W2) at the sub-protective doses for AVP-21D9 and W2 that were determined as described above. At 2 hours prior to anthrax challenge, Swiss Webster mice at 8 weeks of age were administered by the s.c. route either the parental antibodies (AVP-21D9 at 15 \u03bcg\/mouse or W2 at 20 \u03bcg\/mouse; n=10 per group), or the derivative ISTAbs at equivalent number of moles with respect to their corresponding parental antibodies (n=10 per group). For the subsequent challenge, a lethal dose of \u003Cem\u003EB. anthracis\u003C\/em\u003E spores (Ames strain) was administered behind the right foreleg (s.c.,10LD\u003Csub\u003E50\u003C\/sub\u003E). The following control groups were also included in the study: a) control mice that were infected but received buffer vehicle instead of antibody treatment (n=10); b) control mice that were left uninfected and received buffer vehicle only (n=10). Mice were monitored daily for morbidity and mortality for 14 days post treatment. Daily health score assessments were made according to our IACUC-approved Animal Health Score Chart.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-40\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EIII. Post-challenge efficacy studies for the s.c. route of infection\u003C\/h4\u003E\u003Cp id=\u0022p-76\u0022\u003EWe also tested post-challenge efficacy of AVP-21D9-PlyG in comparison to the parental AVP-21D9 antibody. Swiss Webster mice at 8 weeks of age were first infected with a lethal dose of \u003Cem\u003EB. anthracis\u003C\/em\u003E spores (Ames strain) using the s.c. route (5LD\u003Csub\u003E50\u003C\/sub\u003E). Subsequently, at 18-24 hr post infection, the mice were treated s.c. with either the AVP-21D9 at a dose of 330 \u03bcg\/mouse or the derivative ISTAb at equivalent number of moles with respect to IgG (n=24 per group). Control mice were treated with buffer vehicle post challenge (n=20).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-41\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EIV. Pre-challenge efficacy studies for the respiratory route of infection\u003C\/h4\u003E\u003Cp id=\u0022p-77\u0022\u003EThe procedure was the same as described above for the s.c. route of challenge except that a challenge dose of 5LD\u003Csub\u003E50\u003C\/sub\u003E was used and the AVP-21D9 at 65 \u03bcg\/mouse (n=24), or AVP-21D9-PlyG at equivalent number of moles corresponding to 72 \u03bcg\/mouse (n=24), were administered by i.p. route. Control mice received buffer vehicle prior to infection (n=19).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-42\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EV. Post-challenge efficacy studies for the respiratory route of infection\u003C\/h4\u003E\u003Cp id=\u0022p-78\u0022\u003ESwiss Webster mice at 8 weeks of age were first infected with a lethal dose (5LD\u003Csub\u003E50\u003C\/sub\u003E) of \u003Cem\u003EB. anthracis\u003C\/em\u003E spores (Ames strain) via the intranasal (i.n.) route. Subsequently, at 48 hours post infection, the mice were treated i.p. with either the parental AVP-21D9at 195 \u03bcg\/mouse, or with AVP-21D9-PlyG at equivalent number of moles with respect to the parental IgG, corresponding to 216 \u03bcg\/mouse (n=20 per group). Control mice received buffer vehicle prior to infection (n=10).\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-43\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ENHP ISTAb evaluation against inhalation anthrax\u003C\/h3\u003E\u003Cp id=\u0022p-79\u0022\u003EThe NHP study was conducted under biosafety level 3 conditions at Tulane University National Primate Research Center. A total of 14 animals were used in this therapeutic evaluation. Aerosol challenge of the animals was performed using virulent \u003Cem\u003EB. anthracis\u003C\/em\u003E spores (\u003Cem\u003EAmes\u003C\/em\u003E strain). All animals were aerosol exposed to \u003Cem\u003EB. anthracis\u003C\/em\u003E after respiratory measurement by whole-body plethysmography was performed. The aerosol system, target dosing, and exposure dose calculations were performed using published methods (\u003Cem\u003E\u003Ca id=\u0022xref-ref-55-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-55\u0022\u003E55\u003C\/a\u003E\u003C\/em\u003E). Thereafter, animals were treated approximately 24h after \u003Cem\u003EB. anthracis\u003C\/em\u003E exposure. Five animals were treated (IV infusion) with single dose (20 mg\/kg) of AVP-21D9-PlyG (Integrated Biotherapeutics (IBT), Lot # 2184-4A-03 ISTAb-BA01) antibody (Group 1) and another five animals were treated (IV infusion) with single dose (20 mg\/kg) of AVP-21D9 (IBT, Lot # 2184-3A-03-BA01) antibody (Group 2). Four animals were sham treated with an irrelevant mAb (IgG121) at equivalent dosage as the ISTAb cohorts. Any animal demonstrating a combination of clinical signs associated with the onset and progression of inhalation anthrax were euthanized. This study was conducted in strict adherence to TNPRC\u2019s approved protocol (IACUC P0499).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-44\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EImmunogenicity of Anthrax ISTAb in mouse and NHP\u003C\/h3\u003E\u003Cdiv id=\u0022sec-45\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EMouse studies\u003C\/h4\u003E\u003Cp id=\u0022p-80\u0022\u003EMice were immunized i.p. (200 \u00b5l volume) on day 0 with either AVP-21D9 (n=6) at 330 \u00b5g\/mouse or AVP-21D9-PlyG (n=6) at equivalent number of moles with respect to the IgG. Sera were collected on day 28, and antibody titers against PA toxins were determined by ELISA following our method described above.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-46\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003ENHP studies\u003C\/h4\u003E\u003Cp id=\u0022p-81\u0022\u003EOn days 42, 70, and 99, samples from the NHP PK study were analyzed for anti-PlyG antibodies in the ISTAb antibodies treated group. IgG treated and pre bleed samples were used as controls. Serum titers were determined based on the standard ELISA protocol using HRP-conjugated anti-human IgG for detection as described in the following PK NHP section.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-47\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPharmacokinetic (PK) analysis in mouse and NHP\u003C\/h3\u003E\u003Cdiv id=\u0022sec-48\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EMouse studies\u003C\/h4\u003E\u003Cp id=\u0022p-82\u0022\u003ESix ICR mice\/group were treated i.p. (200 \u00b5l volume) with either 330 \u00b5g\/mouse IgG or equivalent number of moles of derivative ISTAb on day 0. Because IACUC protocols (#161007) only allowed 10% blood loss within 2 weeks, animals were further divided into two groups. One subgroup was bled on days 3 and 6, and the other group was bled on days 14 and 21. On day 28, both groups were terminally bled. Quantitative ELISA was used as described above to determine half-life of the antibodies\/ISTAbs.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-49\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003ENHP studies\u003C\/h4\u003E\u003Cdiv id=\u0022sec-50\u0022 class=\u0022subsection\u0022\u003E\u003Ch5\u003EI. Dosing\u003C\/h5\u003E\u003Cp id=\u0022p-83\u0022\u003EBriefly, four Rhesus macaques were treated (IV infusion) with single dose (20 mg\/kg) of AVP-21D9-PlyG antibody (Group 1) and AVP-21D9 (Group 2). Serum samples from day 0, 1, 2, 4, 7, 10, 14, 42, 70, and 99, were used to conduct PK and immunogenicity studies.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-51\u0022 class=\u0022subsection\u0022\u003E\u003Ch5\u003EII. Quantitative ELISA\u003C\/h5\u003E\u003Cp id=\u0022p-84\u0022\u003EQuantitative ELISA was used in this study to measure the concentration of antibody in NHP serum samples, as described previously (\u003Cem\u003E\u003Ca id=\u0022xref-ref-56-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-56\u0022\u003E56\u003C\/a\u003E\u003C\/em\u003E). Briefly, ELISA plates were coated with 100 ng\/well of PA and the concentration of antibody (\u03bcg\/ml) in NHP serum samples were calculated by comparing absorbance with standard antibody.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-52\u0022 class=\u0022subsection\u0022\u003E\u003Ch5\u003EIII. Data analysis\u003C\/h5\u003E\u003Cp id=\u0022p-85\u0022\u003ESoftMax Pro 7.1 software was used to analyze the data. Figures were generated by plotting data using software GraphPad Prism 9. Macros PK solver 2.0 was used to calculated T1\/2, and C\u003Csub\u003Emax\u003C\/sub\u003E of AVP-21D9-PlyG and AVP-21D9 control.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section data-availability\u0022 id=\u0022sec-54\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EData Availability\u003C\/h2\u003E\u003Cp id=\u0022p-86\u0022\u003EAll data produced in the present work are contained in the manuscript\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section fn-group\u0022 id=\u0022fn-group-1\u0022\u003E\u003Ch2\u003EFootnotes\u003C\/h2\u003E\u003Cul\u003E\u003Cli class=\u0022fn-supported-by\u0022 id=\u0022fn-2\u0022\u003E\u003Cp id=\u0022p-2\u0022\u003EFunding: Supported by NIH award AI122666 to RPA, DCN, and RMH; NIH award OD011104 CJR\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ref-list\u0022 id=\u0022ref-list-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EReferences\u003C\/h2\u003E\u003Col class=\u0022cit-list ref-use-labels\u0022\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E1.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-1-1\u0022 title=\u0022View reference 1. in text\u0022 id=\u0022ref-1\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.1\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPelfrene\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMura\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ECavaleiro Sanches\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ECavaleri\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EMonoclonal antibodies as anti-infective products: a promising future?\u003C\/span\u003E \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EClin Microbiol Infect\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E25\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E60\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E64\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DClin%2BMicrobiol%2BInfect%26rft.volume%253D25%26rft.spage%253D60%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E2.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-2-1\u0022 title=\u0022View reference 2. in text\u0022 id=\u0022ref-2\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.2\u0022 data-doi=\u002210.1007\/s10096-011-1509-2\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESong\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EPcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EEur J Clin Microbiol Infect Dis\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E31\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1837\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1845\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DEuropean%2Bjournal%2Bof%2Bclinical%2Bmicrobiology%2B%2526%2Binfectious%2Bdiseases%2B%253A%2B%2Bofficial%2Bpublication%2Bof%2Bthe%2BEuropean%2BSociety%2Bof%2BClinical%2BMicrobiology%26rft.stitle%253DEur%2BJ%2BClin%2BMicrobiol%2BInfect%2BDis%26rft.aulast%253DSong%26rft.auinit1%253DY.%26rft.volume%253D31%26rft.issue%253D8%26rft.spage%253D1837%26rft.epage%253D1845%26rft.atitle%253DPcrV%2Bantibody-antibiotic%2Bcombination%2Bimproves%2Bsurvival%2Bin%2BPseudomonas%2Baeruginosa-infected%2Bmice.%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs10096-011-1509-2%26rft_id%253Dinfo%253Apmid%252F22187351%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1007\/s10096-011-1509-2\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=22187351\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E3.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-3-1\u0022 title=\u0022View reference 3. in text\u0022 id=\u0022ref-3\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.3\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EChen\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EZ.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELiu\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPerry\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EJin\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EStructure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ESci Rep\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E12\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E9028\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DSci%2BRep%26rft.volume%253D12%26rft.spage%253D9028%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E4.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-4-1\u0022 title=\u0022View reference 4. in text\u0022 id=\u0022ref-4\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.4\u0022 data-doi=\u002210.1016\/S0264-410X(98)80112-6\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB. E.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EIvins\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EComparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EVaccine\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E16\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1141\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1148\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E1998\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DVaccine%26rft.stitle%253DVaccine%26rft.aulast%253DIvins%26rft.auinit1%253DB.%2BE.%26rft.volume%253D16%26rft.issue%253D11-12%26rft.spage%253D1141%26rft.epage%253D1148%26rft.atitle%253DComparative%2Befficacy%2Bof%2Bexperimental%2Banthrax%2Bvaccine%2Bcandidates%2Bagainst%2Binhalation%2Banthrax%2Bin%2Brhesus%2Bmacaques.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0264-410X%252898%252980112-6%26rft_id%253Dinfo%253Apmid%252F9682372%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/S0264-410X(98)80112-6\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=9682372\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000074539100013\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E5.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2024.09.23.24313920v1.5\u0022 data-doi=\u002210.1016\/S0264-410X(03)00109-9\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EJendrek\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. F.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELittle\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHem\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMitra\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGiardina\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EEvaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EVaccine\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E21\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E3011\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E3018\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2003\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DVaccine%26rft.stitle%253DVaccine%26rft.aulast%253DJendrek%26rft.auinit1%253DS.%26rft.volume%253D21%26rft.issue%253D21-22%26rft.spage%253D3011%26rft.epage%253D3018%26rft.atitle%253DEvaluation%2Bof%2Bthe%2Bcompatibility%2Bof%2Ba%2Bsecond%2Bgeneration%2Brecombinant%2Banthrax%2Bvaccine%2Bwith%2Baluminum-containing%2Badjuvants.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0264-410X%252803%252900109-9%26rft_id%253Dinfo%253Apmid%252F12798645%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/S0264-410X(03)00109-9\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=12798645\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E6.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-6-1\u0022 title=\u0022View reference 6. in text\u0022 id=\u0022ref-6\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.6\u0022 data-doi=\u002210.1016\/j.vaccine.2009.10.111\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB. D.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELivingston\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. F.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELittle\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELuxembourg\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EEllefsen\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHannaman\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EComparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EVaccine\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E28\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1056\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1061\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2010\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DVaccine%26rft.volume%253D28%26rft.spage%253D1056%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.vaccine.2009.10.111%26rft_id%253Dinfo%253Apmid%252F19896452%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.vaccine.2009.10.111\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=19896452\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000274943300031\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E7.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-7-1\u0022 title=\u0022View reference 7. in text\u0022 id=\u0022ref-7\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.7\u0022 data-doi=\u002210.1126\/science.280.5364.734\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN. S.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDuesbery\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EProteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EScience\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E280\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E734\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E737\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E1998\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DScience%26rft.stitle%253DScience%26rft.aulast%253DDuesbery%26rft.auinit1%253DN.%2BS.%26rft.volume%253D280%26rft.issue%253D5364%26rft.spage%253D734%26rft.epage%253D737%26rft.atitle%253DProteolytic%2BInactivation%2Bof%2BMAP-Kinase-Kinase%2Bby%2BAnthrax%2BLethal%2BFactor%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.280.5364.734%26rft_id%253Dinfo%253Apmid%252F9563949%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEyOiIyODAvNTM2NC83MzQiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNC8wOS8yNS8yMDI0LjA5LjIzLjI0MzEzOTIwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E8.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-8-1\u0022 title=\u0022View reference 8. in text\u0022 id=\u0022ref-8\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.8\u0022 data-doi=\u002210.1006\/bbrc.1998.9040\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EVitale\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EAnthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine\/threonine phosphorylation of MAPKs in cultured macrophages\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBiochem Biophys Res Commun\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E248\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E706\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E711\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E1998\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBiochemical%2Band%2Bbiophysical%2Bresearch%2Bcommunications%26rft.stitle%253DBiochem%2BBiophys%2BRes%2BCommun%26rft.aulast%253DVitale%26rft.auinit1%253DG.%26rft.volume%253D248%26rft.issue%253D3%26rft.spage%253D706%26rft.epage%253D711%26rft.atitle%253DAnthrax%2Blethal%2Bfactor%2Bcleaves%2Bthe%2BN-terminus%2Bof%2BMAPKKs%2Band%2Binduces%2Btyrosine%252Fthreonine%2Bphosphorylation%2Bof%2BMAPKs%2Bin%2Bcultured%2Bmacrophages.%26rft_id%253Dinfo%253Adoi%252F10.1006%252Fbbrc.1998.9040%26rft_id%253Dinfo%253Apmid%252F9703991%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1006\/bbrc.1998.9040\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=9703991\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000075396700048\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E9.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-9-1\u0022 title=\u0022View reference 9. in text\u0022 id=\u0022ref-9\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.9\u0022 data-doi=\u002210.1073\/pnas.79.10.3162\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. H.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELeppla\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EAnthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EProc Natl Acad Sci U S A\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E79\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E3162\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E3166\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E1982\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DPNAS%26rft.stitle%253DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26rft.aulast%253DLeppla%26rft.auinit1%253DS.%2BH.%26rft.volume%253D79%26rft.issue%253D10%26rft.spage%253D3162%26rft.epage%253D3166%26rft.atitle%253DAnthrax%2Btoxin%2Bedema%2Bfactor%253A%2Ba%2Bbacterial%2Badenylate%2Bcyclase%2Bthat%2Bincreases%2Bcyclic%2BAMP%2Bconcentrations%2Bof%2Beukaryotic%2Bcells.%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.79.10.3162%26rft_id%253Dinfo%253Apmid%252F6285339%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMDoiNzkvMTAvMzE2MiI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzA5LzI1LzIwMjQuMDkuMjMuMjQzMTM5MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E10.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-10-1\u0022 title=\u0022View reference 10. in text\u0022 id=\u0022ref-10\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.10\u0022 data-doi=\u002210.1016\/j.coche.2018.01.007\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE. K.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EWagner\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ. A.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMaynard\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EEngineering therapeutic antibodies to combat infectious diseases\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECurr Opin Chem Eng\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E19\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E131\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E141\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2018\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCurr%2BOpin%2BChem%2BEng%26rft.volume%253D19%26rft.spage%253D131%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.coche.2018.01.007%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.coche.2018.01.007\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E11.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-11-1\u0022 title=\u0022View reference 11. in text\u0022 id=\u0022ref-11\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.11\u0022 data-doi=\u002210.1038\/nbt1206-1508\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EV. A.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EFischetti\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ENelson\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESchuch\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EReinventing phage therapy: are the parts greater than the sum?\u003C\/span\u003E \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature biotechnology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E24\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1508\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1511\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2006\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%2Bbiotechnology%26rft.stitle%253DNat%2BBiotechnol%26rft.aulast%253DFischetti%26rft.auinit1%253DV.%2BA.%26rft.volume%253D24%26rft.issue%253D12%26rft.spage%253D1508%26rft.epage%253D1511%26rft.atitle%253DReinventing%2Bphage%2Btherapy%253A%2Bare%2Bthe%2Bparts%2Bgreater%2Bthan%2Bthe%2Bsum%253F%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnbt1206-1508%26rft_id%253Dinfo%253Apmid%252F17160051%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/nbt1206-1508\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=17160051\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000242795800025\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E12.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-12-1\u0022 title=\u0022View reference 12. in text\u0022 id=\u0022ref-12\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.12\u0022 data-doi=\u002210.1007\/s00253-011-3372-6\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESchmelcher\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EWaldherr\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM. J.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELoessner\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EListeria bacteriophage peptidoglycan hydrolases feature high thermoresistance and reveal increased activity after divalent metal cation substitution\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAppl Microbiol Biotechnol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E93\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E633\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E643\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DApplied%2BMicrobiology%2Band%2BBiotechnology%26rft.stitle%253DApplied%2BMicrobiology%2Band%2BBiotechnology%26rft.aulast%253DSchmelcher%26rft.auinit1%253DM.%26rft.volume%253D93%26rft.issue%253D2%26rft.spage%253D633%26rft.epage%253D643%26rft.atitle%253DListeria%2Bbacteriophage%2Bpeptidoglycan%2Bhydrolases%2Bfeature%2Bhigh%2Bthermoresistance%2Band%2Breveal%2Bincreased%2Bactivity%2Bafter%2Bdivalent%2Bmetal%2Bcation%2Bsubstitution.%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs00253-011-3372-6%26rft_id%253Dinfo%253Apmid%252F21720825%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1007\/s00253-011-3372-6\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=21720825\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000299120100018\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E13.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2024.09.23.24313920v1.13\u0022 data-doi=\u002210.1128\/AAC.01625-09\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDaniel\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ESynergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAntimicrob Agents Chemother\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E54\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1603\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1612\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2010\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAntimicrob%2BAgents%2BChemother%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.01625-09%26rft_id%253Dinfo%253Apmid%252F20086153%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjk6IjU0LzQvMTYwMyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzA5LzI1LzIwMjQuMDkuMjMuMjQzMTM5MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E14.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2024.09.23.24313920v1.14\u0022 data-doi=\u002210.1016\/j.jbiotec.2008.09.003\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EManoharadas\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EWitte\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EU.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBlasi\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EAntimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Biotechnol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E139\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E118\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E123\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2009\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2BBiotechnology%26rft.stitle%253DJournal%2Bof%2BBiotechnology%26rft.aulast%253DManoharadas%26rft.auinit1%253DS.%26rft.volume%253D139%26rft.issue%253D1%26rft.spage%253D118%26rft.epage%253D123%26rft.atitle%253DAntimicrobial%2Bactivity%2Bof%2Ba%2Bchimeric%2Benzybiotic%2Btowards%2BStaphylococcus%2Baureus.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jbiotec.2008.09.003%26rft_id%253Dinfo%253Apmid%252F18940209%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.jbiotec.2008.09.003\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=18940209\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000262795600019\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E15.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-15-1\u0022 title=\u0022View reference 15. in text\u0022 id=\u0022ref-15\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.15\u0022 data-doi=\u002210.1016\/j.gene.2009.04.023\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. C.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBecker\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EFoster-Frey\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA. J.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EStodola\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EAnacker\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED. M.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDonovan\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EDifferentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EGene\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E443\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E32\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E41\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2009\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DGene%26rft.volume%253D443%26rft.spage%253D32%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.gene.2009.04.023%26rft_id%253Dinfo%253Apmid%252F19422893%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.gene.2009.04.023\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=19422893\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000268084100004\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E16.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-16-1\u0022 title=\u0022View reference 16. in text\u0022 id=\u0022ref-16\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.16\u0022 data-doi=\u002210.1128\/JB.188.7.2463-2472.2006\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGrundling\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EO.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESchneewind\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ECross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Bacteriol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E188\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E2463\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2472\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2006\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2BBacteriology%26rft.stitle%253DJ.%2BBacteriol.%26rft.aulast%253DGru%2526%2523x0308%253Bndling%26rft.auinit1%253DA.%26rft.volume%253D188%26rft.issue%253D7%26rft.spage%253D2463%26rft.epage%253D2472%26rft.atitle%253DCross-Linked%2BPeptidoglycan%2BMediates%2BLysostaphin%2BBinding%2Bto%2Bthe%2BCell%2BWall%2BEnvelope%2Bof%2BStaphylococcus%2Baureus%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJB.188.7.2463-2472.2006%26rft_id%253Dinfo%253Apmid%252F16547033%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MjoiamIiO3M6NToicmVzaWQiO3M6MTA6IjE4OC83LzI0NjMiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNC8wOS8yNS8yMDI0LjA5LjIzLjI0MzEzOTIwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E17.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-17-1\u0022 title=\u0022View reference 17. in text\u0022 id=\u0022ref-17\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.17\u0022 data-doi=\u002210.1002\/j.1460-2075.1996.tb00859.x\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBaba\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EO.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESchneewind\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ETarget cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EEMBO J\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E15\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E4789\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E4797\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E1996\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DEMBO%2BJ%26rft.volume%253D15%26rft.spage%253D4789%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fj.1460-2075.1996.tb00859.x%26rft_id%253Dinfo%253Apmid%252F8890152%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1002\/j.1460-2075.1996.tb00859.x\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=8890152\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=A1996VL09500002\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E18.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-18-1\u0022 title=\u0022View reference 18. in text\u0022 id=\u0022ref-18\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.18\u0022 data-doi=\u002210.1093\/glycob\/cwt019\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGanguly\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EThe secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EGlycobiology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E23\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E820\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E832\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2013\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DGlycobiology%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fglycob%252Fcwt019%26rft_id%253Dinfo%253Apmid%252F23493680%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1093\/glycob\/cwt019\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=23493680\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E19.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2024.09.23.24313920v1.19\u0022 data-doi=\u002210.1074\/jbc.M605768200\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EChoudhury\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EThe structure of the major cell wall polysaccharide of Bacillus anthracis is species-specific\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Biol Chem\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E281\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E27932\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E27941\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2006\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BBiol%2BChem%26rft_id%253Dinfo%253Adoi%252F10.1074%252Fjbc.M605768200%26rft_id%253Dinfo%253Apmid%252F16870610%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamJjIjtzOjU6InJlc2lkIjtzOjEyOiIyODEvMzgvMjc5MzIiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNC8wOS8yNS8yMDI0LjA5LjIzLjI0MzEzOTIwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E20.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-20-1\u0022 title=\u0022View reference 20. in text\u0022 id=\u0022ref-20\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.20\u0022 data-doi=\u002210.1038\/nature01026\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESchuch\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ENelson\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EV. A.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EFischetti\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EA bacteriolytic agent that detects and kills Bacillus anthracis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E418\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E884\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E889\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2002\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.aulast%253DSchuch%26rft.auinit1%253DR.%26rft.volume%253D418%26rft.issue%253D6900%26rft.spage%253D884%26rft.epage%253D889%26rft.atitle%253DA%2Bbacteriolytic%2Bagent%2Bthat%2Bdetects%2Band%2Bkills%2BBacillus%2Banthracis.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature01026%26rft_id%253Dinfo%253Apmid%252F12192412%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/nature01026\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=12192412\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000177555600040\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E21.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-21-1\u0022 title=\u0022View reference 21. in text\u0022 id=\u0022ref-21\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.21\u0022 data-doi=\u002210.1016\/j.jmb.2006.11.056\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC. J.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPorter\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EThe 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Mol Biol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E366\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E540\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E550\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2007\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bmolecular%2Bbiology%26rft.stitle%253DJ%2BMol%2BBiol%26rft.aulast%253DPorter%26rft.auinit1%253DC.%2BJ.%26rft.volume%253D366%26rft.issue%253D2%26rft.spage%253D540%26rft.epage%253D550%26rft.atitle%253DThe%2B1.6%2BA%2Bcrystal%2Bstructure%2Bof%2Bthe%2Bcatalytic%2Bdomain%2Bof%2BPlyB%252C%2Ba%2Bbacteriophage%2Blysin%2Bactive%2Bagainst%2BBacillus%2Banthracis.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jmb.2006.11.056%26rft_id%253Dinfo%253Apmid%252F17182056%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.jmb.2006.11.056\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=17182056\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E22.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-22-1\u0022 title=\u0022View reference 22. in text\u0022 id=\u0022ref-22\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.22\u0022 data-doi=\u002210.1074\/jbc.M502723200\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL. Y.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELow\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EYang\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPerego\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EOsterman\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER. C.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELiddington\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EStructure and lytic activity of a Bacillus anthracis prophage endolysin\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Biol Chem\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E280\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E35433\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E35439\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2005\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BBiol%2BChem%26rft_id%253Dinfo%253Adoi%252F10.1074%252Fjbc.M502723200%26rft_id%253Dinfo%253Apmid%252F16103125%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamJjIjtzOjU6InJlc2lkIjtzOjEyOiIyODAvNDIvMzU0MzMiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNC8wOS8yNS8yMDI0LjA5LjIzLjI0MzEzOTIwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E23.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-23-1\u0022 title=\u0022View reference 23. in text\u0022 id=\u0022ref-23\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.23\u0022 data-doi=\u002210.1016\/j.virol.2014.11.003\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER. D.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHeselpoth\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ. M.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EOwens\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED. C.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ENelson\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EQuantitative analysis of the thermal stability of the gamma phage endolysin PlyG: a biophysical and kinetic approach to assaying therapeutic potential\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EVirology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E477\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E125\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E132\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2015\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DVirology%26rft.volume%253D477%26rft.spage%253D125%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.virol.2014.11.003%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.virol.2014.11.003\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E24.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2024.09.23.24313920v1.24\u0022 data-doi=\u002210.1016\/j.bbrc.2007.09.002\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EKikkawa\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EFujinami\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESuzuki\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EYasuda\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EIdentification of the amino acid residues critical for specific binding of the bacteriolytic enzyme of gamma-phage, PlyG, to Bacillus anthracis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBiochem Biophys Res Commun\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E363\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E531\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E535\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2007\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBiochemical%2Band%2Bbiophysical%2Bresearch%2Bcommunications%26rft.stitle%253DBiochem%2BBiophys%2BRes%2BCommun%26rft.aulast%253DKikkawa%26rft.auinit1%253DH.%26rft.volume%253D363%26rft.issue%253D3%26rft.spage%253D531%26rft.epage%253D535%26rft.atitle%253DIdentification%2Bof%2Bthe%2Bamino%2Bacid%2Bresidues%2Bcritical%2Bfor%2Bspecific%2Bbinding%2Bof%2Bthe%2Bbacteriolytic%2Benzyme%2Bof%2Bgamma-phage%252C%2BPlyG%252C%2Bto%2BBacillus%2Banthracis.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.bbrc.2007.09.002%26rft_id%253Dinfo%253Apmid%252F17888883%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.bbrc.2007.09.002\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=17888883\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E25.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2024.09.23.24313920v1.25\u0022 data-doi=\u002210.1111\/j.1574-6968.2008.01280.x\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH. S.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EKikkawa\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EUeda\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESuzuki\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EYasuda\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ECharacterization of the catalytic activity of the gamma-phage lysin, PlyG, specific for Bacillus anthracis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EFEMS Microbiol Lett\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E286\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E236\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E240\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2008\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DFEMS%2BMicrobiol%2BLett%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fj.1574-6968.2008.01280.x%26rft_id%253Dinfo%253Apmid%252F18662316%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1111\/j.1574-6968.2008.01280.x\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=18662316\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000258402200013\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E26.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2024.09.23.24313920v1.26\u0022 data-doi=\u002210.1021\/ja3069962\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK. F.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMo\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EEndolysins of Bacillus anthracis bacteriophages recognize unique carbohydrate epitopes of vegetative cell wall polysaccharides with high affinity and selectivity\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Am Chem Soc\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E134\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E15556\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E15562\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bthe%2BAmerican%2BChemical%2BSociety%26rft.stitle%253DJournal%2Bof%2Bthe%2BAmerican%2BChemical%2BSociety%26rft.aulast%253DMo%26rft.auinit1%253DK.%2BF.%26rft.volume%253D134%26rft.issue%253D37%26rft.spage%253D15556%26rft.epage%253D15562%26rft.atitle%253DEndolysins%2Bof%2BBacillus%2Banthracis%2Bbacteriophages%2Brecognize%2Bunique%2Bcarbohydrate%2Bepitopes%2Bof%2Bvegetative%2Bcell%2Bwall%2Bpolysaccharides%2Bwith%2Bhigh%2Baffinity%2Band%2Bselectivity.%26rft_id%253Dinfo%253Adoi%252F10.1021%252Fja3069962%26rft_id%253Dinfo%253Apmid%252F22935003%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1021\/ja3069962\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=22935003\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000308830600066\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E27.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-27-1\u0022 title=\u0022View reference 27. in text\u0022 id=\u0022ref-27\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.27\u0022 data-doi=\u002210.1186\/1472-6750-9-67\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESainathrao\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK. V.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMohan\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EAtreya\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EGamma-phage lysin PlyG sequence-based synthetic peptides coupled with Qdot-nanocrystals are useful for developing detection methods for Bacillus anthracis by using its surrogates, B. anthracis-Sterne and B. cereus-4342\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBMC Biotechnol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E9\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E67\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2009\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBMC%2Bbiotechnology%2B%255Belectronic%2Bresource%255D%26rft.stitle%253DBMC%2BBiotechnol%26rft.aulast%253DSainathrao%26rft.auinit1%253DS.%26rft.volume%253D9%26rft.spage%253D67%26rft.epage%253D67%26rft.atitle%253DGamma-phage%2Blysin%2BPlyG%2Bsequence-based%2Bsynthetic%2Bpeptides%2Bcoupled%2Bwith%2BQdot-nanocrystals%2Bare%2Buseful%2Bfor%2Bdeveloping%2Bdetection%2Bmethods%2Bfor%2BBacillus%2Banthracis%2Bby%2Busing%2Bits%2Bsurrogates%252C%2BB.%2Banthracis-Sterne%2Band%2BB.%2Bcereus-4342.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1472-6750-9-67%26rft_id%253Dinfo%253Apmid%252F19624851%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1186\/1472-6750-9-67\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=19624851\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E28.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-28-1\u0022 title=\u0022View reference 28. in text\u0022 id=\u0022ref-28\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.28\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. I.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMondal\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL. A.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDraper\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER. P.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERoss\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHill\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EBacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EGut Microbes\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E12\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1813533\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DGut%2BMicrobes%26rft.volume%253D12%26rft.spage%253D1813533%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E29.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-29-1\u0022 title=\u0022View reference 29. in text\u0022 id=\u0022ref-29\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.29\u0022 data-doi=\u002210.1073\/pnas.0400187101\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB. R.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHarvey\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EAnchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EProc Natl Acad Sci U S A\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E101\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E9193\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E9198\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2004\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DProc%2BNatl%2BAcad%2BSci%2BU%2BS%2BA%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.0400187101%26rft_id%253Dinfo%253Apmid%252F15197275%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMToiMTAxLzI1LzkxOTMiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNC8wOS8yNS8yMDI0LjA5LjIzLjI0MzEzOTIwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E30.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-30-1\u0022 title=\u0022View reference 30. in text\u0022 id=\u0022ref-30\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.30\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. F.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELittle\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. H.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELeppla\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA. M.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EFriedlander\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EProduction and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EInfect Immun\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E58\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1606\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1613\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E1990\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DInfection%2Band%2BImmunity%26rft.stitle%253DInfect.%2BImmun.%26rft.aulast%253DLittle%26rft.auinit1%253DS%2BF%26rft.volume%253D58%26rft.issue%253D6%26rft.spage%253D1606%26rft.epage%253D1613%26rft.atitle%253DProduction%2Band%2Bcharacterization%2Bof%2Bmonoclonal%2Bantibodies%2Bagainst%2Bthe%2Blethal%2Bfactor%2Bcomponent%2Bof%2BBacillus%2Banthracis%2Blethal%2Btoxin.%26rft_id%253Dinfo%253Apmid%252F2111283%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiaWFpIjtzOjU6InJlc2lkIjtzOjk6IjU4LzYvMTYwNiI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzA5LzI1LzIwMjQuMDkuMjMuMjQzMTM5MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E31.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-31-1\u0022 title=\u0022View reference 31. in text\u0022 id=\u0022ref-31\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.31\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. F.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELittle\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. H.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELeppla\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ECora\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EProduction and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EInfect Immun\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E56\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1807\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1813\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E1988\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DInfection%2Band%2BImmunity%26rft.stitle%253DInfect.%2BImmun.%26rft.aulast%253DLittle%26rft.auinit1%253DS%2BF%26rft.volume%253D56%26rft.issue%253D7%26rft.spage%253D1807%26rft.epage%253D1813%26rft.atitle%253DProduction%2Band%2Bcharacterization%2Bof%2Bmonoclonal%2Bantibodies%2Bto%2Bthe%2Bprotective%2Bantigen%2Bcomponent%2Bof%2BBacillus%2Banthracis%2Btoxin.%26rft_id%253Dinfo%253Apmid%252F3384478%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiaWFpIjtzOjU6InJlc2lkIjtzOjk6IjU2LzcvMTgwNyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzA5LzI1LzIwMjQuMDkuMjMuMjQzMTM5MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E32.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-32-1\u0022 title=\u0022View reference 32. in text\u0022 id=\u0022ref-32\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.32\u0022 data-doi=\u002210.1086\/500148\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EZ.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EChen\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EEfficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Infect Dis\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E193\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E625\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E633\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2006\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1086%252F500148%26rft_id%253Dinfo%253Apmid%252F16453257%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1086\/500148\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=16453257\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000235535500003\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E33.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-33-1\u0022 title=\u0022View reference 33. in text\u0022 id=\u0022ref-33\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.33\u0022 data-doi=\u002210.1128\/AAC.02295-13\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN. V.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMalkevich\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EEfficacy and safety of AVP-21D9, an anthrax monoclonal antibody, in animal models and humans\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAntimicrob Agents Chemother\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E58\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E3618\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E3625\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAntimicrob%2BAgents%2BChemother%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.02295-13%26rft_id%253Dinfo%253Apmid%252F24733473%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjk6IjU4LzcvMzYxOCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzA5LzI1LzIwMjQuMDkuMjMuMjQzMTM5MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E34.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-34-1\u0022 title=\u0022View reference 34. in text\u0022 id=\u0022ref-34\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.34\u0022 data-doi=\u002210.1093\/infdis\/jis462\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER. P.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EAdhikari\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ELower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Infect Dis\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E206\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E915\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E923\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1093%252Finfdis%252Fjis462%26rft_id%253Dinfo%253Apmid%252F22807524%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1093\/infdis\/jis462\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=22807524\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E35.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-35-1\u0022 title=\u0022View reference 35. in text\u0022 id=\u0022ref-35\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.35\u0022 data-doi=\u002210.1128\/JCM.01161-13\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA. M.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPayne\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ECaspase activation as a versatile assay platform for detection of cytotoxic bacterial toxins\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Clin Microbiol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E51\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E2970\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2976\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2013\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BClin%2BMicrobiol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJCM.01161-13%26rft_id%253Dinfo%253Apmid%252F23824772%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamNtIjtzOjU6InJlc2lkIjtzOjk6IjUxLzkvMjk3MCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzA5LzI1LzIwMjQuMDkuMjMuMjQzMTM5MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E36.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-36-1\u0022 title=\u0022View reference 36. in text\u0022 id=\u0022ref-36\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.36\u0022 data-doi=\u002210.1126\/scitranslmed.3009655\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDiGiandomenico\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EA multifunctional bispecific antibody protects against Pseudomonas aeruginosa\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ESci Transl Med\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E6\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E262r\u003C\/span\u003Ea155 (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DSci%2BTransl%2BMed%26rft.volume%253D6%26rft.spage%253D262r%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscitranslmed.3009655%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1126\/scitranslmed.3009655\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E37.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-37-1\u0022 title=\u0022View reference 37. in text\u0022 id=\u0022ref-37\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.37\u0022 data-doi=\u002210.1038\/nature16057\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES. M.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELehar\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ENovel antibody-antibiotic conjugate eliminates intracellular S. aureus\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E527\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E323\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E328\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2015\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D527%26rft.spage%253D323%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature16057%26rft_id%253Dinfo%253Apmid%252F26536114%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/nature16057\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=26536114\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E38.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-38-1\u0022 title=\u0022View reference 38. in text\u0022 id=\u0022ref-38\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.38\u0022 data-doi=\u002210.1046\/j.1365-2958.2002.02889.x\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM. J.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELoessner\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EKramer\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EEbel\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EScherer\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EC-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMol Microbiol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E44\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E335\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E349\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2002\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMolecular%2Bmicrobiology%26rft.stitle%253DMol%2BMicrobiol%26rft.aulast%253DLoessner%26rft.auinit1%253DM.%2BJ.%26rft.volume%253D44%26rft.issue%253D2%26rft.spage%253D335%26rft.epage%253D349%26rft.atitle%253DC-terminal%2Bdomains%2Bof%2BListeria%2Bmonocytogenes%2Bbacteriophage%2Bmurein%2Bhydrolases%2Bdetermine%2Bspecific%2Brecognition%2Band%2Bhigh-affinity%2Bbinding%2Bto%2Bbacterial%2Bcell%2Bwall%2Bcarbohydrates.%26rft_id%253Dinfo%253Adoi%252F10.1046%252Fj.1365-2958.2002.02889.x%26rft_id%253Dinfo%253Apmid%252F11972774%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1046\/j.1365-2958.2002.02889.x\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=11972774\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E39.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-39-1\u0022 title=\u0022View reference 39. in text\u0022 id=\u0022ref-39\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2024.09.23.24313920v1.39\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN. P.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ETaylor\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-source\u0022\u003EPfizer fails phase 3 C. diff vaccine test but still spies possible path forward\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/www.fiercebiotech.com\/biotech\/pfizer-fails-phase-3-c-diff-vaccine-test-still-spies-possible-path-forward#:~:text=Pfizer%20had%20planned%20to%20accrue,42%20cases%20within%20four%20years\u0022\u003Ehttps:\/\/www.fiercebiotech.com\/biotech\/pfizer-fails-phase-3-c-diff-vaccine-test-still-spies-possible-path-forward#:~:text=Pfizer%20had%20planned%20to%20accrue,42%20cases%20within%20four%20years\u003C\/a\u003E., (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E40.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-40-1\u0022 title=\u0022View reference 40. in text\u0022 id=\u0022ref-40\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.40\u0022 data-doi=\u002210.3389\/fmicb.2015.01320\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC. W.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ETsai\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMorris\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EApproval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration \u0022Animal Rule\u0022\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EFront Microbiol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E6\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1320\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2015\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DFront%2BMicrobiol%26rft.volume%253D6%26rft.spage%253D1320%26rft_id%253Dinfo%253Adoi%252F10.3389%252Ffmicb.2015.01320%26rft_id%253Dinfo%253Apmid%252F26648915%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3389\/fmicb.2015.01320\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=26648915\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E41.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-41-1\u0022 title=\u0022View reference 41. in text\u0022 id=\u0022ref-41\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.41\u0022 data-doi=\u002210.1086\/430708\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG. M.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESubramanian\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EA phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EClin Infect Dis\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E41\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E12\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E20\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2005\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DClin%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1086%252F430708%26rft_id%253Dinfo%253Apmid%252F15937757%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1086\/430708\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=15937757\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000229530400003\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E42.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-42-1\u0022 title=\u0022View reference 42. in text\u0022 id=\u0022ref-42\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.42\u0022 data-doi=\u002210.1128\/IAI.00712-06\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EVitale\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EProphylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EInfect Immun\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E74\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E5840\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E5847\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2006\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DInfection%2Band%2BImmunity%26rft.stitle%253DInfect.%2BImmun.%26rft.aulast%253DVitale%26rft.auinit1%253DL.%26rft.volume%253D74%26rft.issue%253D10%26rft.spage%253D5840%26rft.epage%253D5847%26rft.atitle%253DProphylaxis%2Band%2BTherapy%2Bof%2BInhalational%2BAnthrax%2Bby%2Ba%2BNovel%2BMonoclonal%2BAntibody%2Bto%2BProtective%2BAntigen%2BThat%2BMimics%2BVaccine-Induced%2BImmunity%26rft_id%253Dinfo%253Adoi%252F10.1128%252FIAI.00712-06%26rft_id%253Dinfo%253Apmid%252F16988263%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiaWFpIjtzOjU6InJlc2lkIjtzOjEwOiI3NC8xMC81ODQwIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjQvMDkvMjUvMjAyNC4wOS4yMy4yNDMxMzkyMC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E43.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-43-1\u0022 title=\u0022View reference 43. in text\u0022 id=\u0022ref-43\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.43\u0022 data-doi=\u002210.4161\/mabs.1.6.10195\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMazumdar\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ERaxibacumab\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMAbs\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E1\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E531\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E538\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2009\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.stitle%253DmAbs%26rft.aulast%253DMazumdar%26rft.auinit1%253DS.%26rft.volume%253D1%26rft.issue%253D6%26rft.spage%253D531%26rft.epage%253D538%26rft.atitle%253DRaxibacumab.%26rft_id%253Dinfo%253Adoi%252F10.4161%252Fmabs.1.6.10195%26rft_id%253Dinfo%253Apmid%252F20068396%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.4161\/mabs.1.6.10195\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=20068396\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E44.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-44-1\u0022 title=\u0022View reference 44. in text\u0022 id=\u0022ref-44\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.44\u0022 data-doi=\u002210.1073\/pnas.1619249114\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERaz\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ELysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EProceedings of the National Academy of Sciences of the United States of America\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E114\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E4781\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E4786\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DProceedings%2Bof%2Bthe%2BNational%2BAcademy%2Bof%2BSciences%2Bof%2Bthe%2BUnited%2BStates%2Bof%2BAmerica%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.1619249114%26rft_id%253Dinfo%253Apmid%252F28428342%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMToiMTE0LzE4LzQ3ODEiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNC8wOS8yNS8yMDI0LjA5LjIzLjI0MzEzOTIwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E45.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-45-1\u0022 title=\u0022View reference 45. in text\u0022 id=\u0022ref-45\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.45\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERaz\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESerrano\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EThaker\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EAlston\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EV. A.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EFischetti\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ELysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAntimicrobial agents and chemotherapy\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E62\u003C\/span\u003E, (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2018\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E46.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-46-1\u0022 title=\u0022View reference 46. in text\u0022 id=\u0022ref-46\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.46\u0022 data-doi=\u002210.1128\/AAC.01625-09\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDaniel\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ESynergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAntimicrob Agents Chemother\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E54\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1603\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1612\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2010\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAntimicrob%2BAgents%2BChemother%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.01625-09%26rft_id%253Dinfo%253Apmid%252F20086153%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjk6IjU0LzQvMTYwMyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzA5LzI1LzIwMjQuMDkuMjMuMjQzMTM5MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E47.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-47-1\u0022 title=\u0022View reference 47. in text\u0022 id=\u0022ref-47\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.47\u0022 data-doi=\u002210.1128\/AAC.00890-10\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPastagia\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EA novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAntimicrob Agents Chemother\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E55\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E738\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E744\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2011\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAntimicrob%2BAgents%2BChemother%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.00890-10%26rft_id%253Dinfo%253Apmid%252F21098252%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjU1LzIvNzM4IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjQvMDkvMjUvMjAyNC4wOS4yMy4yNDMxMzkyMC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E48.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-48-1\u0022 title=\u0022View reference 48. in text\u0022 id=\u0022ref-48\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.48\u0022 data-doi=\u002210.1016\/j.celrep.2017.03.049\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK. A.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHowell\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003ECooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECell Rep\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E19\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E413\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E424\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCell%2BRep%26rft.volume%253D19%26rft.spage%253D413%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.celrep.2017.03.049%26rft_id%253Dinfo%253Apmid%252F28402862%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.celrep.2017.03.049\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=28402862\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E49.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-49-1\u0022 title=\u0022View reference 49. in text\u0022 id=\u0022ref-49\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.49\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF. H.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ENiesen\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBerglund\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EVedadi\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EThe use of differential scanning fluorimetry to detect ligand interactions that promote protein stability\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature protocols\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E2\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E2212\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2221\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2007\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%2Bprotocols%26rft.volume%253D2%26rft.spage%253D2212%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E50.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-50-1\u0022 title=\u0022View reference 50. in text\u0022 id=\u0022ref-50\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.50\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER. P.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EAdhikari\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EDevelopment of a novel multiplex electrochemiluminescent-based immunoassay for quantification of human serum IgG against 10 Staphylococcus aureus toxins\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Immunol Methods\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E430\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E33\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E42\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2016\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BImmunol%2BMethods%26rft.volume%253D430%26rft.spage%253D33%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E51.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-51-1\u0022 title=\u0022View reference 51. in text\u0022 id=\u0022ref-51\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.51\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM. M.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ENgundi\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB. D.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMeade\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET. L.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELin\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EW. J.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ETang\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED. L.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBurns\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EComparison of three anthrax toxin neutralization assays\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EClinical and vaccine immunology: CVI\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E17\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E895\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E903\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2010\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DClinical%2Band%2Bvaccine%2Bimmunology%253A%2BCVI%26rft.volume%253D17%26rft.spage%253D895%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E52.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-52-1\u0022 title=\u0022View reference 52. in text\u0022 id=\u0022ref-52\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.52\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED. C.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDailey\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EKaiser\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER. H.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESchloemer\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EFactors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EInfect Immun\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E55\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1541\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1546\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E1987\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DInfection%2Band%2BImmunity%26rft.stitle%253DInfect.%2BImmun.%26rft.aulast%253DDailey%26rft.auinit1%253DD%2BC%26rft.volume%253D55%26rft.issue%253D7%26rft.spage%253D1541%26rft.epage%253D1546%26rft.atitle%253DFactors%2Binfluencing%2Bthe%2Bphagocytosis%2Bof%2BClostridium%2Bdifficile%2Bby%2Bhuman%2Bpolymorphonuclear%2Bleukocytes.%26rft_id%253Dinfo%253Apmid%252F3596798%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiaWFpIjtzOjU6InJlc2lkIjtzOjk6IjU1LzcvMTU0MSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzA5LzI1LzIwMjQuMDkuMjMuMjQzMTM5MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E53.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2024.09.23.24313920v1.53\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDwyer\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGadjeva\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EOpsonophagocytic assay\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMethods Mol Biol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E1100\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E373\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E379\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMethods%2BMol%2BBiol%26rft.volume%253D1100%26rft.spage%253D373%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E54.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-54-1\u0022 title=\u0022View reference 54. in text\u0022 id=\u0022ref-54\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.54\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER. L.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBurton\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM. H.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ENahm\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EDevelopment of a fourfold multiplexed opsonophagocytosis assay for pneumococcal antibodies against additional serotypes and discovery of serological subtypes in Streptococcus pneumoniae serotype 20\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EClinical and vaccine immunology: CVI\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E19\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E835\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E841\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DClinical%2Band%2Bvaccine%2Bimmunology%253A%2BCVI%26rft.volume%253D19%26rft.spage%253D835%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E55.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-55-1\u0022 title=\u0022View reference 55. in text\u0022 id=\u0022ref-55\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.55\u0022 data-doi=\u002210.1016\/j.vascn.2003.07.001\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ. M.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHartings\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC. J.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERoy\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EThe automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Pharmacol Toxicol Methods\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E49\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E39\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E55\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2004\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bpharmacological%2Band%2Btoxicological%2Bmethods%26rft.stitle%253DJ%2BPharmacol%2BToxicol%2BMethods%26rft.aulast%253DHartings%26rft.auinit1%253DJ.%2BM.%26rft.volume%253D49%26rft.issue%253D1%26rft.spage%253D39%26rft.epage%253D55%26rft.atitle%253DThe%2Bautomated%2Bbioaerosol%2Bexposure%2Bsystem%253A%2Bpreclinical%2Bplatform%2Bdevelopment%2Band%2Ba%2Brespiratory%2Bdosimetry%2Bapplication%2Bwith%2Bnonhuman%2Bprimates.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.vascn.2003.07.001%26rft_id%253Dinfo%253Apmid%252F14670693%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.vascn.2003.07.001\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=14670693\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2024%2F09%2F25%2F2024.09.23.24313920.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E56.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-56-1\u0022 title=\u0022View reference 56. in text\u0022 id=\u0022ref-56\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2024.09.23.24313920v1.56\u0022 data-doi=\u002210.1128\/IAI.00352-07\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ. W.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPeterson\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EHuman monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EInfect Immun\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E75\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E3414\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E3424\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2007\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DInfect%2BImmun%26rft_id%253Dinfo%253Adoi%252F10.1128%252FIAI.00352-07%26rft_id%253Dinfo%253Apmid%252F17452469%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiaWFpIjtzOjU6InJlc2lkIjtzOjk6Ijc1LzcvMzQxNCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzA5LzI1LzIwMjQuMDkuMjMuMjQzMTM5MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003C\/ol\u003E\u003C\/div\u003E\u003Cspan class=\u0022highwire-journal-article-marker-end\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Cspan class=\u0022related-urls\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_zP7WWIfzbyzvaM63L39cNV2juU_1XVH7wduFK9gcMNI.js\u0022\u003E\u003C\/script\u003E\n\u003C\/body\u003E\u003C\/html\u003E"}